Apparatus and methods for assisted breathing by transvascular nerve stimulation

Information

  • Patent Grant
  • 10293164
  • Patent Number
    10,293,164
  • Date Filed
    Friday, May 26, 2017
    6 years ago
  • Date Issued
    Tuesday, May 21, 2019
    4 years ago
Abstract
A catheter may include an outer layer defining a plurality of apertures therethrough, and a body defining at least one longitudinal lumen therein. The body may be within the outer layer, and the apertures may be radially outward of the lumen. The catheter may also include a plurality of electrodes positioned in or on the catheter, with each electrode being electrically exposed through an aperture of the plurality of apertures. A ribbon cable may extend through the lumen and include a plurality of leads, with the plurality of leads being electrically connected to the plurality of electrodes. The plurality of leads and electrodes may be formed by the deposition of conductive inks or paints, or by the electrodeposition of copper or other conductive metals or materials.
Description
TECHNICAL FIELD

Embodiments of this disclosure relate to medical apparatus and particularly to apparatus applicable for the restoration, enhancement, or modulation of physiological functions. Specific embodiments provide apparatus for stimulating the phrenic nerves to contract the diaphragm muscle to assist breathing by transvascular electrical stimulation of nerves.


BACKGROUND

Electrical stimulation of nerves is widely applied in the treatment of a range of conditions and may be applied to control muscle activity or to generate sensations. Muscles and nerves may be stimulated by placing electrodes in, around, or near the muscles and nerves and by activating the electrodes by means of an implanted or external source of energy (e.g. electricity).


The diaphragm muscle provides important functions for respiration. The phrenic nerves normally transmit signals from the brain to cause the contractions of the diaphragm muscle necessary for breathing. However, various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include:

    • permanent or temporary injury or disease affecting the spinal cord or brain stem;
    • Amyotrophic Lateral Sclerosis (ALS);
    • decreased day or night ventilatory drive (e.g. central sleep apnea, Ondine's curse); and
    • decreased ventilatory drive while under the influence of anesthetic agents and/or mechanical ventilation.


      These conditions affect a significant number of people.


Intubation and positive pressure mechanical ventilation (MV) may be used for periods of several hours or several days, sometimes weeks, to help critically ill patients breathe while in intensive care units (ICU). Some patients may be unable to regain voluntary breathing and thus require prolonged or permanent mechanical ventilation. Although mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects. Mechanical ventilation:

    • often causes ventilator-induced lung injury (VILI) and alveolar damage which can lead to accumulation of fluid in the lungs and increased susceptibility to infection (ventilator-associated pneumonia; VAP);
    • commonly requires sedation to reduce discomfort and anxiety in acutely intubated patients;
    • leads to rapid atrophy of the disused diaphragm muscle (ventilator-induced diaphragm dysfunction, VIDD);
    • can adversely affect venous return because the lungs are pressurized and the diaphragm is inactive;
    • interferes with eating and speaking;
    • requires apparatus that is not readily portable; and
    • increases the risk of dying if the patient fails to regain normal breathing and becomes ventilator-dependent.


A patient who is sedated and connected to a mechanical ventilator cannot breathe normally because the central neural drive to the diaphragm and accessory respiratory muscles is suppressed. Inactivity leads to muscle disuse atrophy and an overall decline in well-being. Diaphragm muscle atrophy occurs rapidly and can be a serious problem to the patient. According to a published study in organ donor patients (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008) after only 18 to 69 hours of mechanical ventilation, all diaphragm muscle fibers had shrunk on average by 52-57%. Muscle fiber atrophy results in muscle weakness and increased fatigability. Therefore, ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent. It has been estimated that over 600,000 US patients will be ventilator dependent and require prolonged mechanical ventilation by the year 2020 (Zilberberg et al., Critical Care Medicine, 36(5): 1451-1455, 2008).


It may also be necessary during MV to deliver or remove one or more fluids or to obtain sensor readings from within the patient. Smaller patients, such as, for example, neonates, may require smaller medical instruments to perform the aforementioned procedures. Additionally, as with any medical procedure, the risk of injury to the patient increases with the length and complexity of the medical procedure.


There remains a need for cost-effective, practical, surgically simple and minimally invasive apparatus and methods that may be applied to stimulate breathing, deliver treatment, and perform tests. There is also a need for apparatus and methods for facilitating patients on MV to regain the capacity to breathe naturally and to be weaned from MV.


SUMMARY

Embodiments of the present disclosure relate to, among other things, medical apparatus and methods for nerve stimulation. Specific embodiments provide apparatus for stimulating breathing by trans-vascular electrical stimulation of nerves. Each of the embodiments disclosed herein may include one or more of the features described in connection with any of the other disclosed embodiments.


In one embodiment, a catheter may include an outer layer defining a plurality of apertures therethrough, and a body defining at least one longitudinal lumen therein. The body may be within the outer layer, and the apertures may be radially outward of the lumen. A plurality of electrodes may be positioned in or on the catheter, and each electrode may be electrically exposed through an aperture of the plurality of apertures, or alternatively mounted on the surface of the catheter. A ribbon cable may extend through the lumen and include a plurality of leads. The plurality of leads may electrically connect to the plurality of electrodes.


The catheter may further include one or more of the following features. The lumen may be a groove or recessed channel exposed along a portion of the circumference of the body along at least a portion of the length of the body, and the groove may be at least partially covered by an outer layer. The plurality of leads may be at least partially surrounded by a non-conducting material. The ribbon cable may include a plurality of corrugations. The catheter may also include at least one filler positioned within at least a portion of the corrugations. The corrugations may be positioned radially inward of at least one electrode. The catheter may also include at least one fluid lumen and a guide wire lumen.


Further, the catheter may include a connector feed and an application specific integrated circuit (“ASIC”) radially inward of the outer layer. The ASIC may connect the connector feed to the ribbon cable. The ribbon cable may include several, for example three, branches of ribbon cable, and the at least one longitudinal lumen may include three longitudinal lumens spaced circumferentially around an exterior of the body and radially inward of the outer layer. In this example, the three branches may extend distally from the ASIC, and each of the three branches may connect to at least one electrode through a corresponding longitudinal lumen. One branch of the three branches may include at least one lead that electrically connects at least one proximal electrode and at least one other lead that electrically connects at least one distal electrode. The plurality of apertures may include a plurality of proximal apertures and a plurality of distal apertures. The proximal apertures may include two longitudinally extending rows, and the distal apertures may include two longitudinally extending rows. One row of proximal apertures may be circumferentially aligned with one row of distal apertures. The ribbon cable may be electrically connected to at least one electrode via a connection and an electrode coupler, and the electrode coupler may longitudinally overlap with the ribbon cable and be positioned radially inward of a portion of the electrode.


In another alternative or additional embodiment, the catheter may include an outer layer defining a plurality of apertures therethrough, and a body radially within the outer layer. The catheter may also include a radial extension, extending helically around and radially outward from the body and within the outer layer, as well as a ribbon cable coupled to a plurality of electrodes. The ribbon cable may extend around an exterior of the body between portions of the radial extension, with each electrode of the plurality of electrodes electrically exposed through an aperture of the plurality of apertures, the apertures in this case being formed in an outer insulating layer over the electrodes.


The catheter may further include one or more of the following features. The plurality of electrodes may be coupled to the ribbon cable at approximately a 45 degree angle relative to a longitudinal axis of the ribbon cable. The catheter may include at least one ASIC positioned radially inward of the outer layer, and the at least one ASIC may electrically connect the ribbon cable to at least one of the plurality of electrodes. The body may include at least one groove exposed along a circumference of the body along at least a portion of the length of the body, and the at least one ASIC may be positioned within the at least one groove. The catheter may include at least one ASIC for each of the plurality of electrodes, and each ASIC may electrically connect the ribbon cable to the corresponding electrode. The catheter may include a conductive liner positioned over or within the apertures.


In another alternative or additional embodiment, the catheter may include an outer layer or sleeve. The outer layer may include first and second longitudinally extending rows of distal apertures in the outer layer, and the outer layer and/or the catheter may also include a first radiopaque feature for confirming an orientation of the first row of distal apertures relative to the second row of distal apertures.


The catheter may further include one or more of the following features. The catheter may further include first and second longitudinally extending rows of proximal apertures in the outer layer. The outer layer may include a second radiopaque feature for confirming an orientation of the first row of proximal apertures relative to the second row of proximal apertures. The first row of proximal apertures may be circumferentially aligned with one of either the first row of distal apertures or the second row of distal apertures. The second row of proximal apertures may be circumferentially offset from both the first row of distal apertures and the second row of distal apertures. The second radiopaque feature may include a radiopaque marker positioned circumferentially opposite to a line extending between the first and second rows of proximal apertures. The first radiopaque feature may be at a distal portion of the outer layer, and the second radiopaque feature may be at a proximal portion of the outer layer. The catheter may further include a hub, and the hub may include an orientation feature. The hub may also include a port configured to couple the hub to a proximal portion of the catheter in a particular orientation.


Further aspects of the disclosures and features of example embodiments are illustrated in the appended drawings and/or described in the text of this specification and/or described in the accompanying claims. It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed. As used herein, the terms “comprises,” “comprising,” or other variations thereof, are intended to cover a non-exclusive inclusion such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such a process, method, article, or apparatus. Additionally, the term “exemplary” is used herein in the sense of “example,” rather than “ideal.” As used herein, the terms “about,” “substantially,” and “approximately,” indicate a range of values within +/−5% of a stated value.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate non-limiting embodiments of the present disclosure and together with the description serve to explain the principles of the disclosure.



FIG. 1 illustrates the anatomy of selected nerves and blood vessels in a person's neck and upper torso, along with an exemplary catheter and control unit.



FIG. 2 illustrates a ventral view of an exemplary catheter having windows that align with nerve-stimulating electrodes within the catheter, inserted in a person's neck and upper torso, according to an exemplary embodiment.



FIG. 3 illustrates a perspective view of a catheter with conductors and electrodes printed on the exterior of the catheter, according to an exemplary embodiment.



FIG. 4 illustrates a perspective view of a tubular member with conductors, an application specific integrated circuit, and electrodes, where the tubular member may be an internal part of a catheter, according to an exemplary embodiment.



FIG. 5 illustrates a schematic view of the conductors, application specific integrated circuit, and electrodes of the exemplary embodiment shown in FIG. 4.



FIG. 6 illustrates a cross-sectional view of a catheter with an exemplary tubular member including conductors, electrodes, and lumens, according to an exemplary embodiment.



FIG. 7A illustrates an exemplary embodiment of a conductor and electrode assembly of a catheter, and FIG. 7B illustrates an exploded view of another exemplary embodiment of a conductor and electrode assembly.



FIG. 8 illustrates a perspective view of a portion of a tubular member with axial lumens and a radial extension, according to an exemplary embodiment.



FIG. 9 illustrates a portion of a conductive ribbon cable with electrodes that may be coupled around the tubular member of FIG. 8 within the radial extension, according to an exemplary embodiment.



FIG. 10 illustrates a cross-sectional view of a catheter with the exemplary tubular member of FIG. 8 and the ribbon cable with electrodes of FIG. 9, according to an exemplary embodiment.



FIG. 11 illustrates a cross-sectional view of a catheter with an exemplary tubular member similar to FIG. 6 with a plurality of application specific integrated circuits.



FIG. 12 illustrates the anatomy of selected nerves and blood vessels in a person's neck and upper torso along with an exemplary catheter and control unit connected via a wireless connection, according to an exemplary embodiment.



FIG. 13 illustrates an exemplary catheter with radiopaque electrodes, according to an exemplary embodiment.



FIG. 14 illustrates an exemplary catheter with radiopaque electrodes and orientation-aiding indicators, according to an exemplary embodiment.





DETAILED DESCRIPTION

Throughout the following description, specific details are set forth to provide a more thorough understanding to persons skilled in the art. The following description of examples of the technology is not intended to be exhaustive or to limit the system to the precise forms of any example embodiment. Accordingly, the description and drawings are to be regarded in an illustrative, rather than a restrictive, sense.


Reference will now be made in detail to examples of the present disclosure described above and illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.


The terms “proximal” and “distal” are used herein to refer to the relative positions of the components of an exemplary medical device or insertion device. When used herein, “proximal” refers to a position relatively closer to the exterior of the body or closer to an operator using the medical device or insertion device. In contrast, “distal” refers to a position relatively further away from the operator using the medical device or insertion device, or closer to the interior of the body.


General Overview


In general, embodiments of this disclosure relate to medical devices and methods for electrically stimulating a patient's nerves. In one embodiment, the patient's nerves may be stimulated to activate the diaphragm to restore or control breathing.


The medical devices described herein may include several components, including a catheter having a tubular member and one or more electrode assemblies, a signal generator to provide stimulation energy to the electrode assemblies, and one or more sensors to sense the condition of the patient and adjust the stimulation signals. The medical devices may further include a steering mechanism. Various embodiments of catheters are disclosed, including windowed catheters, multi-lumen catheters, and radiopaque catheters. In addition, various embodiments of electrode assemblies are disclosed, which may be used alone, in combination with other electrode assemblies, and with any of the disclosed tubular members that form the outer portion of the catheters.


The different embodiments of the various medical device components (e.g., electrode assemblies, steering mechanisms, etc.) may be combined and used together in any logical arrangement. Furthermore, individual features or elements of any described embodiment may be combined with or used in connection with the individual features or elements of other embodiments. The various embodiments may further be used in different contexts than those specifically described herein. For example, the disclosed electrode structures may be combined or used in combination with various deployment systems known in the art for various diagnostic and/or therapeutic applications.


During use, the medical devices (e.g., a catheter with one or more electrode assemblies) may be inserted into a patient's blood vessels such that the electrode assemblies are near the patient's nerves. The electrode assemblies may then be used for transvascular electrical stimulation of the patient's nerves. The disclosed devices may be optimized for rapid, temporary deployment in a patient and easy removal from the patient. The disclosed devices may be used, for example, for restoring breathing, treating conditions such as disuse muscle atrophy and chronic pain, or for any other procedures involving nerve stimulation. The disclosed devices may be used to treat acute or chronic conditions.


Medical Device Overview: Catheter and Electrode Assemblies



FIG. 1 illustrates a medical system 10 that includes a catheter 12 including a plurality of lumens and having two proximal electrode assemblies 14 and two distal electrode assemblies 16. The electrode assemblies 14 and 16 may be positioned on or within a tubular member or catheter body of catheter 12. Catheter 12 may be positioned within a patient through the patient's external or internal jugular veins 18, brachiocephalic veins 20, superior vena cava 22, brachial vein (not shown), radial vein (not shown), and/or left subclavian vein 24 such that the proximal electrode assemblies 14 are directed towards the left phrenic nerve 26, and the distal electrode assemblies 16 are directed laterally towards the right phrenic nerve 28. As such, when positioned, catheter 12 may receive signals from a control unit 30 and, using electrode assemblies 14 and 16, stimulate the left phrenic nerve 26 and/or the right phrenic nerve 28.


Catheter 12 may further include a manifold 32 that extends external to the patient. Electrical cable 34 and pigtail lumen 36 extend from manifold 32. Cable 34 and pigtail lumen 36 may include cable connectors 38 and 40 to connect external elements, and cable 34 may be coupled to electrical control unit 30 via cable connector 38. The cables 34 and 36 may be formed of electrical leads (not shown) that connect to electrode assemblies 14 and 16. Cable connectors 38 and 40 may be attached (e.g. by solder, crimp, PCB, etc.) to the cables 34 and 36, and one or both of cable connectors 38 and 40 may include a threading 41 (as shown in FIGS. 2 and 3). Alternatively or additionally, one or both of cable connectors 38 and 40 may include a push-to-pull compression fitting or a slip-lock fitting (not shown). Control unit 30 and other elements may be electronically connected to the components within catheter 12 to both send and receive signals and/or data to selectively stimulate electrode assemblies 14, 16 and/or monitor the patient and any response to the stimulation. Alternatively or additionally, cables 34 and 36 may include one or more lumens or fluid lines that connect to one or more internal lumens in catheter 12, and cable connectors 38 and 40 may form sealed connections with a fluid port or other source. Catheter 12 may also include an atraumatic distal tip 42.


As shown in FIG. 2, catheter 12 may include two axially extending rows of proximal apertures or windows 44. Each axially extending row includes proximal windows 44 positioned at the same circumferential position around the exterior of catheter 12, but at different axial positions along the exterior of catheter 12. The two rows of proximal windows 44 may be substantially aligned. For instance, as illustrated in FIG. 2, one proximal window 44 of a first row is located at the same axial position as a window of a second row, but at a different circumferential position around the exterior of the catheter 12. When positioned in a patient, the two rows of proximal windows 44 may be substantially posterior facing, and at least one proximal window 44 may face, abut or be positioned in the vicinity of the left phrenic nerve 26.


Catheter 12 may also include two axially extending rows of distal apertures or windows 46. Again, each axially extending row includes distal windows 46 positioned at the same circumferential position around the exterior of catheter 12, but at different axial positions along the exterior of catheter 12. The two rows of distal windows 46 may be unaligned such that one distal window 46 of a first row is axially between two distal windows 46 of a second row. For instance, as illustrated in FIG. 2, one distal window 46 of a first row is located at a different axial position and at a different circumferential position around the exterior of the catheter 12 than a window of the second row. When positioned in a patient, the two rows of distal windows 46 may be substantially laterally facing (to the patient's right), and at least one distal window 46 may face, abut, or be positioned in the vicinity of the right phrenic nerve 28. Therefore, in the example shown in FIG. 2, when viewed ventrally, the two unaligned rows of three distal windows 46 may appear as one row of six distal windows 46, because one row is anterior facing (shown as dark windows) and one row is posterior facing (shown as lighter windows).


The proximal windows 44 and the distal windows 46 may be positioned on catheter 12 such that one row of proximal windows 44 is circumferentially aligned (i.e., the same circumferential position but different axial position) with one row of distal windows 46, but another row of proximal windows 44 and another row of distal windows 46 are each circumferentially offset from the aligned rows on the catheter 12. Proximal electrode assemblies 14 may include individual proximal electrodes 48 that are positioned to be aligned with (e.g., radially inward of and underneath) proximal windows 44, and distal electrode assemblies 16 may include individual distal electrodes 50 that are positioned to be aligned with (e.g., radially inward of and underneath) distal windows 46. Windows 44, 46 may expose electrodes 48, 50, allowing for a conductive path between sets or pairs of electrodes 48, 50 and surrounding tissue, including the blood vessel lumen in which catheter 12 is inserted.


In one embodiment illustrated in FIG. 2, catheter 12 includes twelve proximal windows 44 (two rows of six windows 44) and six distal windows 46 (two rows of three windows 46). However, in other embodiments, the catheter 12 may include fewer or more rows and numbers of proximal or distal windows 46. For example, in other embodiments, the catheter 12 may include two, four, eight, ten, twelve, or more proximal windows 44 arranged in one, two, three, or more rows, and/or two, four, six, eight, ten, twelve or more distal windows 46 arranged in one, two, three, or more rows. The proximal windows 44 and distal windows 46 may be configured in pairs such that the catheter 12 has an even number of proximal windows 44 and an even number of distal windows 46. However, the number of windows 44 or 46 may also be an odd number.


The windows 44, 46 may be cut (e.g. by a laser, manual skive, drill, punch, etc.) through the exterior wall of catheter 12, or the windows 44, 46 may be formed by any other suitable method, such as during an extrusion process. 3-D printing, or other manufacturing process. The windows 44, 46 may extend along the longitudinal axis of catheter 12, or they may have a rectangular, oval, square, or any other shape. The windows 44, 46 may be apertures configured to allow electrical signals to travel from an interior lumen of the catheter 12 to the exterior of the catheter 12. In an additional or alternative embodiment, the windows 44, 46 may be covered by a material that allows electrical signals to pass through. As can be seen in the figures, the proximal windows 44 may be rotationally offset from the distal windows 46. In other words, in one embodiment, a straight line drawn proximally through a row of distal windows 46 does not necessarily pass through a row of proximal windows 44. In other embodiments, one or more rows of proximal windows 44 may be aligned with a corresponding row of distal windows 46. Furthermore, the characteristics of the proximal windows 44 may differ from the characteristics of the distal windows 46.


The dimensions of catheter 12 may be customized in accordance with the anatomy of a particular patient (e.g., different sizes of humans, pigs, chimpanzees, etc.). However, in some embodiments, the length of the section of the catheter 12 that includes the proximal windows 44 may be 10 cm or less, between 3-5 cm, or between 1-3 cm. The distance between two adjacent proximal windows 44 (whether the windows are circumferentially adjacent or longitudinally adjacent on the same row of windows) may be 5 cm or less, 3 cm or less, may be around 1 cm, or may be less than 1 cm. The length of the section of the catheter 12 that includes the distal windows 46 may be 6 cm or less, between 2-4 cm, or between 1-2 cm. The distance between two adjacent distal windows 46 (whether circumferentially adjacent or longitudinally adjacent on the same row of windows) may be 5 cm or less, 3 cm or less, may be around 1 cm, or may be less than 1 cm. The length of the section of the catheter 12 between proximal windows 44 and distal windows 46, which may be free of windows, may be 12 cm or less, 10 cm or less, or 8 cm or less. The windows 44, 46 may have a length of 6 mm or less, 5 mm or less, 4 mm or less, 3 mm or less, 2 mm or less, or 1 mm or less. In one embodiment, the windows 44, 46 may have a length that is less than the length of corresponding electrodes that are electrically exposed through the windows. These catheter dimensions are exemplary only, and the catheter 12 may have dimensions that vary from the above ranges and specific measurements. For neonatal applications, the distance between the distal electrodes and the proximal electrodes may be very small, perhaps less than 1 cm or even less than 1 mm. Alternatively, in this situation, a signal electrode array may contain electrode combinations which suitably serve to stimulate both the left phrenic nerve and the right phrenic nerve.


Additionally, catheter 12 may include windows 44, 46 in different configurations than discussed above. For example, catheter 12 may include more than two longitudinally extending rows of proximal windows 44 positioned at different circumferential positions. As such, catheter 12 may provide for more than two proximal electrode assemblies 14, or for two proximal electrode assemblies 14 to be positioned in different configurations in catheter 12. Alternatively or additionally, catheter 12 may be rotatable about the longitudinal axis such that windows 44, 46 at various circumferential positions may be positioned in different positions relative to the targeted nerves. Varying configurations may provide for various stimulation patterns with which catheter 12 may stimulate targeted nerves.


In one embodiment, medical system 10 may be assembled by positioning proximal and distal electrode assemblies 14, 16 within the outer, windowed tubular member of catheter 12 such that proximal electrodes 48 are at least partially exposed through proximal windows 44 and distal electrodes 50 are at least partially exposed through distal windows 46. The proximal electrode assemblies 14 may include the proximal electrodes 48 arranged and oriented to most effectively stimulate a nerve extending at transverse or right angles to the catheter 12 (e.g., the left phrenic nerve 26 in FIGS. 1 and 2), and the distal electrode assemblies 16 may include the distal electrodes 50 arranged and oriented to most effectively stimulate a nerve extending approximately parallel to the catheter 12 (e.g., the right phrenic nerve 28 in FIGS. 1 and 2). In an additional or alternative embodiment, the proximal electrode assemblies 14 may include proximal electrodes 48 arranged and oriented to most effectively stimulate a nerve extending approximately parallel to the catheter 12, and the distal electrode assemblies 16 may include distal electrodes 50 arranged and oriented to most effectively stimulate a nerve extending at transverse or right angles to the catheter 12. In the embodiments described above, the distal electrode assemblies 16 have been placed in a more distal location along catheter 12 than the proximal electrode assemblies 14. However, in other embodiments, the electrode assemblies 14, 16 may be rearranged within the catheter 12, and the proximal windows 44 and distal windows 46 of the catheter 12 may be configured to accommodate the alternative placement of the electrode assemblies 14, 16.


Distal tip 42 may be a tapered distal end portion of catheter 12. Distal tip 42 may be open at the distal end to allow a guide wire 52 to pass through and distally beyond catheter 12. Distal tip 42 may have a smaller circumference than the body of catheter 12. Distal tip 42 may be softer than other portions of catheter 12, be atraumatic, and have rounded edges. Distal tip 42 may be made of an aliphatic polyester-based thermoplastic polyurethane with a portion, for example, of 20% barium sulfate. Distal tip 42 may be formed and/or coupled to a remainder of catheter 12 by melting an extruded tube of thermoplastic polyurethane in a mold using, for example, an induction heater.


The medical system 10 may be used to rhythmically activate the diaphragm by inserting the catheter 12, with one or more electrode assemblies 14 and 16, percutaneously into central veins of a patient, as shown by FIG. 1. Guide wire 52 may be used to position catheter 12 within a patient. For example, the Seldinger technique may be used, in which guide wire 52 is inserted through a hypodermic needle into a vein. As in the example shown in FIGS. 1 and 2, the catheter 12 may be inserted into the left subclavian vein 24 and advanced into the superior vena cava 22. In an unillustrated example, catheter 12 may be inserted into the left jugular vein and advanced into the superior vena cava 22. In either example, catheter 12 may be inserted in a minimally-invasive way and may be temporarily placed into, and thus removable from, the patient. The distal tip 42 of the catheter 12 may then be passed over the guide wire 52 and advanced into the vein. The shape and mechanical properties of the catheter 12 may be designed to urge the catheter 12 to gently hug the vein wall in regions adjacent to the right and left phrenic nerves, as shown in FIG. 1. The guide wire 52 may also be positioned such that it is adjacent to the right and left phrenic nerves before the distal tip of the catheter 12 is passed over the guide wire 52. When the catheter 12 is positioned, the guide wire 52 may extend distal to the catheter 12 from distal tip 42, through an internal lumen in catheter 12, through pigtail lumen 36, and proximally out of a cable connector 40, as shown in FIG. 2.


Once the catheter 12 is fully inserted into the patient, various electrodes or electrode combinations can be tested to locate nerves of interest and to determine which electrodes most effectively stimulate the nerves of interest. For example, in one embodiment, testing may be done to locate the right phrenic nerve 28 and to determine which group of distal electrodes 50 in the distal electrode assemblies 16 most effectively stimulate the right phrenic nerve 28. Similarly, testing may be done to locate the left phrenic nerve 26 and to determine which group of proximal electrodes 48 in the proximal electrode assemblies 14 most effectively stimulate the left phrenic nerve 26. This testing and nerve location may be controlled and/or monitored via control unit 30, which may include testing programming and/or applications. For example, control unit 30 may test the electrodes and electrode combinations to determine which pair of bipolar distal electrodes 50 most effectively stimulate the right phrenic nerve 28, and which pair of bipolar proximal electrodes 48 most effectively stimulate the left phrenic nerve 26. Alternatively, control unit 30 may test the electrodes or electrode combinations to determine which tripolar or multipolar electrode combinations most effectively stimulate the phrenic nerves (for example, one cathode electrode and two anode electrodes, two cathode electrodes and one anode electrode, one cathode electrode and three anode electrodes, three cathode electrodes and one anode electrode, two cathode electrodes and two anode electrodes, one cathode electrode and four anode electrodes, four cathode electrodes and one anode electrode, one cathode electrode and five anode electrodes, five cathode electrodes and one anode electrode, etc.).


As a non-limiting example, testing could involve the use of a signal generator to systematically send electrical impulses to selected electrodes. By observing the patient's condition or by using sensors (either within or separate from the catheter 12), the ideal stimulation electrodes may be identified. Electrodes may serve as both stimulating electrodes and as sensing electrodes, and the medical system 10 may be integrated into a mechanical ventilator, which can be used to sense the patient's condition. Moreover, for example, control unit 30 may be programmed and/or activated to (a) select a first stimulation group of electrodes from the proximal electrode assemblies 14 to stimulate the left phrenic nerve 26, (b) select a second stimulation group of electrodes from the distal electrode assemblies 16 to stimulate the right phrenic nerve 28, (c) select a first stimulation current for the first stimulation group of electrodes to stimulate the left phrenic nerve 26, and (d) select a second stimulation current for the second stimulation group of electrodes to stimulate the right phrenic nerve 28. The selection of electrodes and current level may be pre-programmed or input based on the patient's characteristics, or the control unit 30 may test different electrode groups and current levels and monitor the patient's response to determine the electrode pairs and current levels. For example, the monitoring of the patient's response may include manual palpitation of the thoracic region, sensors to sense the movement of the patient's chest wall (e.g., accelerometers, optical devices, camera based sensors, etc.), airflow sensors, airway pressure sensors, central venous pressure sensors, etc. Control unit 30 may include a stimulation signal generator to generate the stimulation signals and to selectively transmit the generated signals to the selected electrodes.


Once ideal electrode combinations (e.g. pair, triplets, etc.) have been identified, an electrical potential may be created between a pair of selected bipolar electrodes, for example, a pair of proximal electrodes 48 each aligning with a proximal window 44. The arrangement of the electrodes 48 and the windows 44 may create an electrical field in the vicinity of windows 44, and thus in the vicinity of the targeted nerve, for example, the left phrenic nerve 26. During nerve stimulation, however, electrical current flows from one or more of the electrodes 48 to one or more of the other of the electrodes 48, flowing through the windows 44 and through the blood and surrounding tissues. The catheter 12 with windows 44 therefore acts as an insulating barrier that constrains and focuses the electrical field, rather than allowing the electrical field to expand radially outwards in all directions as the electrical field might with ring electrodes. The focused electrical field allows target nerve stimulation at lower, and thus safer, energy levels and avoids stimulating unwanted nerves or other structures. In some embodiments, the stimulation current may be between 10 and 6000 nC (nano-coulombs) or between 50-500 nC, reducing the risk of overstimulation or unwanted activation of nearby structures such as other nerves, muscles, or the heart.


In a further embodiment, any of the proximal electrodes 48 or the distal electrodes 50 may be used to measure electrical signals or other data from within the patient's body. In other words, in addition or alternatively to emitting or receiving electrical energy to produce a localized current for nerve stimulation, the electrodes 48, 50 may serve as sensors that receive electrical signals or other types of information from the patient.


Printed Ink Catheter



FIG. 3 illustrates an exemplary catheter 12A with electrode assemblies 14A, 16A and leads 54A printed directly onto the exterior of catheter 12A. Proximal electrode assemblies 14A, distal electrode assemblies 16A, and leads 54A may be formed by conductive inks (such as silver flakes or carbon flakes suspended in polymer or graphene ink). The conductive inks may be deposited and adhered directly onto the catheter 12A and sealed with an outer polyurethane or other flexible, insulating film or sheath, leaving the electrodes 48A, 50A of the electrode assemblies 14A, 16A at least partially exposed. The insulating film or sheath may be applied to the conductive inks that form electrode assemblies 14A, 16A and leads 54A, or may be applied to the catheter 12A as a whole. In some instances, the insulating film or sheath may be applied by 3-D printing or by other manufacturing processes. For example, at least one tubular sleeve (not shown) may be slid over at least a portion the exterior of catheter 12A. The tubular sleeve may be formed by extrusion, and/or the sleeve may be formed of a thin, thermoplastic material such as, but not limited to, polyamide, polyether block amide, polyurethane, silicone rubber, nylon, polyethylene, fluorinated hydrocarbon polymers, etc. Examples of polymer materials suitable for use in the sleeve are commercially available under the trademarks PEBAX™ and PELLETHANE™. The sleeve may be thermally bonded or mechanically attached to catheter 12A.


The exposed electrodes 48A, 50A may be coated with a conductive material (e.g., titanium nitride) in order to, for example, provide corrosion resistance and reduce the likelihood of silver oxide formation, which may be toxic. The conductive leads 54A electrically connect the proximal electrode assemblies 14A and the distal electrode assemblies 16A through cable 34 to control unit 30 or other electronics. The leads 54A connected to distal electrode assemblies 16A may travel proximally along catheter 12A beyond the proximal electrode assemblies 14A, for example, on the back side of catheter 12A in FIG. 3.


As shown in FIG. 3, proximal electrode assemblies 14A and distal electrode assemblies 16A may extend partially circumferentially around a portion of catheter 12A, and, for example, may be partially helical around a portion of the exterior of catheter 12A. Proximal electrode assemblies 14A and distal electrode assemblies 16A may be approximately 90 degrees displaced about a circumference of catheter 12A. For example, as shown in FIG. 3, proximal electrode assemblies 14A may extend helically 180 degrees around the front portion of the catheter 12A, and distal electrode assemblies 16A may extend helically 180 degrees around the top (plane of the paper) portion of the catheter 12A, and the proximal electrode assemblies 14A and distal electrode assemblies 16A are approximately 90 degrees displaced at right angles to the plane of the paper. As such, the partially helical electrodes 48A, 50A may increase the conductive surface area and broaden the electrical field produced by the electrodes 48A, 50A while still focusing the field on a portion of the circumference of the catheter 12A positioned proximate to, abutting, or facing the target nerve.


The use of printed electrodes and leads may reduce the overall complexity of the design while maximizing the useable catheter lumen space, without drastically changing the catheter profile or flexibility. The use of printed electrodes 14A, 16A and printed leads 54A also allows freedom of electrode position and electrode shape, permitting optimization of field focus and minimum energy for nerve recruitment and capture. Printed leads 54A may be helically disposed between printed electrodes 14A, 16A to allow for greater flexibility in bending the catheter 12A. Additionally, in some embodiments, the profile of the catheter 12A may be reduced because of the space saved by using electrodes printed on the exterior of the catheter 12A, for example, for use with neonate or other young patients. In an additional or alternative embodiment, one or several catheter lumens may be used for fluid delivery, blood sampling, central venous pressure monitoring, or to accommodate tools, sensors, or other objects. In another additional or alternative embodiment, several of the catheter lumens may be eliminated, allowing for larger catheter lumens and/or reducing the cross-sectional size of the catheter 12A.


Catheters Including Ribbon Cables


Referring now to FIGS. 4-6, a catheter body or tubular member 56 may form the interior of the catheter 12. As shown, tubular member 56 may include a guide wire lumen 58, at least two fluid lumens 60 and 62, and three lumens or grooves 64, 66, and 68. As discussed, guide wire 52 may be threaded though guide wire lumen 58. The fluid lumens 60 and 62 may be used to deliver and/or remove fluids at a treatment site. Additionally or alternatively, fluid lumens 60 and/or 62 may be used for other medical devices to treat, diagnose, or sense conditions at the surgical site. Grooves 64, 66, and 68 may, for example, be approximately rectangular in a cross-section. Grooves 64, 66, and 68 may extend radially to the outer surface of tubular member 56 and longitudinally along the tubular member 56. Grooves 64, 66, and 68 are exposed along at least a circumference and a portion of a length of tubular member 56 and may be spaced approximately 90 degrees from each other around the circumference of the tubular member 56. Grooves 64, 66, and 68 in tubular member 56 may accommodate electrical leads to connect control unit 30 to proximal electrodes 48 (shown in FIGS. 4 and 6) and distal electrodes 50. As shown, electrodes 48, 50 may extend longitudinally over a portion of tubular member 56 and may approximate the width of the grooves 64, 66, and 68 and/or the width of windows 44, 46.


In one aspect, the leads may be formed by ribbon cables 70′, 70″, and 70′″. As shown in FIG. 4, a connector feed 72 may be positioned within groove 66 and recessed within the outer perimeter of tubular member 56. Connector feed 72 may send and transmit signals to an application specific integrated circuit (“ASIC”) 74. Connector feed 72 may also be formed by a ribbon cable. ASIC 74 may then be connected to three ribbon cables 70′, 70″, and 70′″ that branch out and connect to the proximal electrode assemblies 14 and distal electrode assemblies 16. Ribbon cables 70′, 70″, and 70′″ may be accommodated in grooves 64, 66, and 68 in tubular member 56. Partially circumferential grooves 69 extend around at least part of a circumference of the tubular member 56 to allow the ribbon cables 70′, 70″, and 70′″ to branch out without extending away from or interfering with the tubular member 56 fitting within an outer covering of catheter 12.


Ribbon cables 70′, 70″, and 70′″ are flexible and include multiple insulated leads 76 (some of which are labeled in FIG. 6) connected along their lengths to form a single, flexible planar structure. The planar structure is flexible to allow the formation of other shapes, such as bends and/or corrugations. The leads 76 within ribbon cables 70′, 70″, and 70′″ may include a wire or a rod-like conductive member. Leads 76 are surrounded by a layer of non-conducting material 78, such as insulation (FIG. 6). Ribbon cables 70′, 70″, and 70′″ may be similar to printed circuits formed using thin flexible polyimide substrates with copper plated conductors. Typical dimensions include an insulation base layer about 0.0381 mm (0.0015 in) thick, a copper conductor about 0.0381 mm (0.0015 in) thick by 0.0508 mm (0.002 in) wide, an insulation cover layer about 0.0381 mm (0.0015 in) thick, and a lateral spacing between conductors of about 0.0381 mm (0.0015 in). The ribbon cables 70′, 70″, and 70′″ may be secured within the grooves 64, 66, and 68 by application of a heat shrink polyolefin tube around the outside of tubular member 56. Windows may be formed by ablating the heat shrink tube locally over the electrodes 48, 50 using a CO2 laser. As such, any of the leads 76 may be uninsulated at a point along the length of catheter 12 and coupled to an electrode 48, 50, such as, for example, a flexible foil electrode or an electrode formed according to any of the embodiments described herein and exposed through a window 44, 46 of catheter 12.


In one example, connector feed 72 may include approximately 8 electrical leads in a ribbon cable, and ribbon cables 70′, 70″, and 70′″ may include enough electrical leads 76 to send electrical signals to each electrode 48, 50 of the proximal electrode assemblies 14 and distal electrode assemblies 16. For instance, connector feed 72 may include an electrical lead for each of power, ground, data stream, anode signal, cathode signal, and leads to send and receive signals from various elements in catheter 12. Ribbon cables 70 connect to each electrode 48, 50 of the electrode assemblies 14, 16 in order to stimulate the targeted nerves.


ASIC 74 may serve to direct the signals received from connector feed 72. For example, based on the received signals, ASIC 74 may direct electrical signals to one or a plurality of the electrodes 48, 50 of the proximal electrode assemblies 14 and the distal electrode assemblies 16. As such, there may be only one connection and/or connector at the proximal end of catheter 12 to transmit electrical or other signals distally from, for example, control unit 30, to the proximal and distal electrode assemblies 14 and 16, providing further space within tubular member 56 for the fluid lumens 60 and 62, additional medical instruments, and/or allowing the tubular member 56 and the remainder of the catheter 12 to be smaller. ASIC 74 allows for a reduction in conductors in the connector feed 72, and thus reduces the number of couplings between connector feed 72 and ASIC 74, improving reliability and reducing cost. Moreover, ASIC 74 permits the use of a connector with 8 or 9 pins, rather than a connector with 19 pins, further improving reliability and reducing the risk of signal interference or misalignment.



FIG. 5 illustrates a schematic view of the connector feed 72, ASIC 74, ribbons cables 70′, 70″, 70′″, and the electrode assemblies 14, 16. Ribbon cables 70′, 70″, 70′″ may be three separate ribbon cables, or may be one ribbon cable that branches out into three ribbon cables. As discussed, connector feed 72 may include 8 conductor leads 54 connected to ASIC 74. ASIC 74 connects to ribbon cables 70′, 70″, 70′″ to selectively deliver signals to one or a plurality of the proximal electrodes 48 or the distal electrodes 50. Proximal electrodes 48 and distal electrodes 50 may be mounted or otherwise physically and electrically connected to the corresponding ribbon cable 70′, 70″, 70′″. In one example, ribbon cables 70′, 70″, 70′″ may include one lead 76 per electrode 48, 50, with the particular lead 76 terminating in an uninsulated portion where the lead 76 is coupled to the electrode 48, 50 by mechanical rivet, solder, crimping, or another technique.


As shown in FIGS. 4 and 5, one ribbon cable 70′ may include one proximal electrode assembly 14 with six proximal electrodes 48. One ribbon cable 70″ may include one proximal electrode assembly 14 with six proximal electrodes 48 and one distal electrode assembly 16 with three distal electrodes 50. One ribbon cable 70′″ may include one distal electrode assembly 16 with three distal electrodes 50. ASIC 74 may decode the signals from connector feed 72 and determine if a particular electrode 48, 50 is to be an anode or a cathode, so each of the ribbon cables 70′, 70″, 70′″ may only require one lead for each of the electrodes 48, 50 connected to that ribbon cable 70′, 70″, 70′″. In this situation, ribbon cable 70′ may include six leads 76 to connect to the six proximal electrodes 48. Ribbon cable 70″ may include nine leads 76 to connect to the six proximal electrodes 48 and three distal electrodes 50. Ribbon cable 70′″ may include as few as three leads 76. The proximal electrodes 48 of the two proximal electrode assemblies 14 may be aligned (positioned at the same axial position and different circumferential positions), and the distal electrodes 50 of the two distal electrode assemblies 16 may be displaced (positioned at different axial positions and different circumferential positions). The electrodes 48, 50 may also take different orientations and arrangements in order to locate and/or stimulate the target nerves.



FIG. 6 illustrates an axial cross-sectional view of a proximal portion of the catheter 12, including tubular member 56 and an outer layer or sheath 75, at a position of proximal electrode assemblies 14. As shown, guide wire lumen 58, fluid lumens 60 and 62, and grooves 64, 66, and 68 longitudinally pass through tubular member 56. Ribbon cables 70′, 70″, and 70′″ with leads 76 are positioned within grooves 64, 66, and 68. Proximal electrodes 48 are mounted over ribbon cables 70′ and 70″ and are exposed through proximal windows 44. Although not shown, distal electrodes 50 are mounted and/or connected to ribbon cables 70″ and 70′″ and exposed through distal windows 46 in a similar manner to the proximal electrodes 48.


In another aspect of this disclosure, the tubular member 56 may include printed ink conductors and electrodes similar to that shown in FIG. 3. In this example, the printed ink conductors may extend distally from ASIC 74 and branch out in a similar manner as discussed above, but with the printed ink conductors extending along the circumferential surface of the tubular member 56. The printed ink conductors may connect to printed electrodes, and signals may be selectively transmitted via the ASIC 74 to the electrodes through the printed ink conductors.


Tubular member 56 may be extruded polyurethane (or any other suitable biocompatible material). Sheath 75 fitting over tubular member 56 may be made of any biocompatible plastic or other material. In one aspect, sheath 75 is a 0.002 m thick polyolefin shrink tube that may be positioned around tubular member 56 and shrunk down using a heat gun or other heating source. Windows 44 may be formed by ablating the heat shrink tube locally over the electrodes 48, 50 using a CO2 laser. Alternatively, sheath 75 may be a 3-D printed insulation layer with windows 44 over electrodes 48, 50 formed by open portions during the 3-D printing.



FIG. 7A illustrates a longitudinal cross-sectional view of a portion of one groove 66 in the tubular member 56, and FIG. 7B illustrates an exploded view of a portion of a ribbon cable 70″ that may fit within groove 66. The configuration in FIG. 7A shows an arrangement where electrode 48 is coupled at one end of the electrode to the appropriate lead 76 of ribbon cable 70″ and corrugations 82 in ribbon cable 70″ pass beneath electrode 48. Such an arrangement may be used if the distance between electrodes 48, 50 is short, and using as many corrugations as possible provides maximum longitudinal and rotational flexibility for the ribbon cables 70′, 70″, and 70′″ in the catheter. Alternatively or additionally, as in FIG. 7B, corrugations 82 in ribbon cables 70′, 70″, and 70′″ may be located between electrodes only, and not under the electrodes


As shown in FIG. 7A, ribbon cable 70″ may be coupled to proximal electrode 48 via a connection 80. Connection 80 electrically and physically connects electrode 48 to the appropriate lead 76 of ribbon cable 70″ that corresponds to electrode 48. Connection 80 may be, for example, a wire connection with solder or a rivet. Electrode 48 may longitudinally overlap with ribbon cable 70″, and may extend longitudinally and be positioned radially underneath a portion of tubular member 56. A portion of electrode 48 may be exposed through window 44 and may be partially covered by a non-insulating and/or conductive cover 49.


Proximal electrode 48 may be exposed via proximal window 44 in sheath 75. A proximal electrode 48, along with the other electrodes 48, 50, may be a sheet Platinum-Iridium (Ptlr) electrode with a thickness of approximately 0.0381-0.0508 mm (0.0015-0.002 in). Ribbon cable 70″ may be coupled to the other proximal electrodes 48 and the distal electrodes 50 in the same manner as illustrated in FIG. 7A. Electrodes 48, 50 may be various other known electrode assemblies, for example, ring electrodes fixed to the exterior of catheter 12. Electrodes 48, 50 may also be formed of other conductive materials, including platinum, gold, stainless steel, titanium nitride, MP35N, palladium, or another appropriate material. Electrodes 48, 50 may also be coupled to ribbon cables 70′, 70″, and 70′″ with conductive adhesive, heat fusion, crimping, riveting, microwelding, or another appropriate method. Electrodes 48, 50 may also include an insulating coating over a portion of the electrodes 48, 50 that may facilitate directional targeting of one or more nerves.


Each ribbon cable 70′, 70″, and 70′″ may also include corrugations 82 within at least one or more portions of grooves 64, 66, and 68. Corrugations 82 may provide greater longitudinal and lateral flexibility and bendability of the catheter 12 and the internal components. Corrugations 82 may pass underneath an electrode 48, as shown in FIG. 7A. Alternatively or additionally, corrugations 82 may be positioned along ribbon cables 70′, 70″, and 70′″ between longitudinally adjacent electrodes 48, 50, as shown in FIG. 7B. In this aspect, a filler block 84 may support electrode 48, 50 and ribbon cable 70″. A filler strip 86 may include contours 88 that mirror the corrugations 82. Contours 88 may extend radially inwardly to fit within corrugations 82. Filler strip 86 may be positioned on a radially outward side of ribbon cable 70″ to support the corrugations 82 of ribbon cable 70″ between electrodes 48, 50. Corrugations 82 of ribbon cable 70″ may be unsupported or open on the radially inward side of corrugations opposite to filler strip 86 and contours 88, which may increase the longitudinal or lateral flexibility. Filler blocks 84 and filler strips 86 may be elastomeric and may be sized to fit within grooves 64, 66, and 68 of tubular member 56.



FIGS. 8-10 illustrate an alternative embodiment of the disclosure, including tubular member 100 and helical ribbon cable 101 that may be radially surrounded by an outer layer, sleeve, or sheath 175 to form a catheter 112 to stimulate target nerves as discussed above, according to another aspect of this disclosure.



FIG. 8 illustrates a portion of tubular member 100. Tubular member 100 is sized to fit within sheath 175 in a similar manner to tubular member 56 (FIG. 10). Tubular member 100 includes a series of lumens 102, which may include a guide wire lumen and fluid lumens that may function as discussed above. Tubular member 100 includes a radial extension 104. Radial extension 104 extends radially outward from tubular member 100. Radial extension 104 may be integrally formed of the same material as tubular member 100, or may be a separate element attached to or positioned around tubular member 100. Radial extension 104 may helically extend along an outer surface of tubular member 100 and include a helical pitch 106. Electrode locations 108 may be located such that there are at least portions of radial extension 104 between electrode locations 108, as shown in FIG. 8, to form an electrode pitch 110. One or both of tubular member 100 and radial extension 104 may be formed by, for example, extrusion, molding, or 3-D printing using XYZ and rotary motions to deposit a flexible polymer around a mandrel, with some or all of the polymer being sacrificial.



FIG. 9 illustrates a portion of helical ribbon cable 101 with electrodes 114 mounted on helical ribbon cable 101. FIG. 9 shows a top view of cable 101 in a straight, flat configuration prior to its placement around tubular member 100. Helical ribbon cable 101 may be formed and may function similarly to ribbon cables 70′, 70″, and 70′″ with leads 76 surrounded by non-conducting material 78 as discussed above. Additionally, electrodes 114 may be coupled to ribbon cable 101 as with electrodes 48, 50 and ribbon cables 70′, 70″, and 70′″. Helical ribbon cable 101 may include an upper conductor 103 having multiple leads that communicate with the upper electrodes 114, and a lower conductor 105 also having multiple leads communicating with the lower electrodes 114. Conductors 103 and 105 are surrounded by and separated by insulating layers 107.


Electrodes 114 are mounted on helical ribbon cable 101 at an angle to the axis of the helical ribbon cable 101 such that the electrodes lie at the correct axially disposed angle when the helical ribbon cable 101 is wrapped around the tubular member 100 in the helical recess defined by radial extensions 104. After wrapping the helical ribbon cable 101 around the tubular member, the electrodes 114 adopt the alignment shown by locations 108 in FIG. 8. In one example, if the electrodes 114 are to be oriented with the electrodes' shorter dimension disposed circumferentially around the tubular member 100 after helical ribbon cable 101 is helically wrapped, then electrodes 114 may be mounted on helical ribbon cable 101 at approximately a 59 degree angle relative to a longitudinal axis of the helical ribbon cable 101. The length of helical ribbon cable 101 between paired electrodes 114 corresponds to an electrode pitch 110 between paired electrode locations 108. Therefore, when the helical ribbon cable 101 is wrapped around tubular member 100 between radial extensions 104, paired electrodes 114 align with electrode locations 108. For example, if the electrode pitch 110 is about 10 mm, and the tubular member 100 has an outside diameter of about 3.2 mm, then the distance between sets of paired electrodes on helical ribbon cable 101 is approximately 23 mm.


As shown in FIG. 10, catheter 112 may include tubular member 100 and helical ribbon cable 101 positioned within sheath 175. Electrodes 114 and helical ribbon cable 101 may function as discussed above, without interfering with lumens 102 and other radially internal elements of tubular member 100. Moreover, electrodes 114 may be electrically and physically coupled to helical ribbon cable 101 via connection 116. Connection 116 may be, for example, a wire connection, a solder connection, a rivet, or another mechanical and electrical connection to mechanically and electrically connect electrode 114 to helical ribbon cable 101. Electrodes 114 may then be exposed via an electrode window 118. Sheath 175 may also radially surround tubular member 100, and sheath 175 may comprise one or more insulating layers of flexible polyimide, shrink tubing, and/or a flexible filler.



FIG. 11 illustrates an aspect of the present disclosure that may be incorporated in any of the foregoing aspects. As shown in FIG. 11, each electrode 114 may be coupled to a small ASIC 120. For example, helical ribbon cable 101 may be coupled to a tubular member 100A as part of a catheter 112A. Tubular member 100A may include guide wire lumen 58, two fluid lumens 60 and 62, and grooves 64, 66, and 68, similar to as shown in FIG. 4. Small ASICs 120 may be positioned within grooves 64, 66, and 68 radially between electrodes 48, 50 and guidewire lumen 58. The small ASICs 120 allow for a reduction of conductive leads 76. For example, unless an ASIC 120 is located locally for each electrode 48, 50, there must be a separate lead 76 for each electrode 48, 50. With an ASIC 120 specific to each electrode, the ASIC 120 may decode a signal from a control unit and determine whether the signal applies to that particular electrode 48, 50. Therefore, helical ribbon cable 101, or other ribbon cable in other aspects of this disclosure, would be connected through the electrode-specific ASICs 120 to all electrodes 48, 50, and the helical ribbon cable 101 would only need five conductive leads 76 (an anode reference, a cathode reference, a power, a ground, and a data line) for any number of electrodes 48, 50. It is further noted that locally located ASICs 120 require a groove or recess in the tubular member 100A, but may also be incorporated in other tubular members or catheters of this disclosure. For instance, grooves or recesses may be extruded in tubular member 100A, and tubular member 100A may be extruded, 3-D printed, or otherwise formed to include helical lumens such that the grooves or recesses do not interfere with the lumens. Grooves or recesses may also be helical, and the helical grooves or recesses, along with helical lumens, may be formed by extruding the tubular member as with longitudinal grooves, and lumens, and then heat setting the tubular member in a twisted state. Each electrode 114 may be exposed through a window (similar to as shown in FIG. 10), or may be partially covered by a non-insulating and/or conductive element 121, as shown in FIG. 11.


Once positioned within a patient, the catheter 112A of FIG. 11, with helical ribbon 101 and small ASICs 120, may be used to stimulate the target nerves as discussed above. In particular, the conductive leads of the helical ribbon cable 101 may be reduced because each lead of the same helical ribbon cable 101 may connect to each small ASIC 120. Based on the signals through the leads of the helical ribbon cable 101, each small ASIC 120 controls whether the electrical signals through leads are emitted through the particular electrodes 114. Similar to the example shown in FIGS. 4-6, the catheter 112A of FIG. 11 may only include one connection at the proximal end of catheter 112A to transmit electrical or other signals distally to the proximal and distal electrode assemblies 14 and 16, providing further space within tubular member 100A for the fluid lumens 60 and 62, additional medical instruments, and/or allowing the tubular member 100A and catheter 112A to be smaller.


Wireless Connections to Control Unit



FIG. 12 illustrates an alternative medical system 210 with similar elements to the medical system 10 of FIG. 1 shown by 200 added to the reference numbers. Medical system 210 includes a wireless connection from control unit 230 to catheter 212. Catheter 212 may be inserted and positioned as discussed with respect to FIG. 1. Catheter 212 may include proximal and distal electrode assemblies 214, 216 that are exposed through proximal and distal windows as discussed above.


Instead of proximal connector 32, catheter 212 may include a manifold or hub 211 at a proximal end or coupled to the proximal end of catheter 212. Hub 211 may be positioned external to the patient when catheter 212 is inserted. Hub 211 may include a plurality of lumens that may connect to the guide wire and fluid lumens within catheter 212. In one aspect, hub 211 may be connected to a fluid port 213 and a wireless unit 215. Fluid port 213 may include one lumen connected through hub 211 to a lumen in catheter 212, or fluid port 213 may include a plurality of lumens connected through hub 211 to lumens within catheter 212, including a guide wire port. Wireless unit 215 may include a battery and a receiver/transmitter. The receiver/transmitter of wireless unit 215 may be in wireless communication with control unit 230, via, for example, a Bluetooth connection. As such, control unit 230 may send signals to and receive signals from wireless unit 215. Wireless unit 215 may then be coupled to one or more leads or ribbon cables to transmit electrical signals distally to the proximal and distal electrode assemblies 214, 216, and the signals may be distributed via one or more ASICs within catheter 212 to stimulate a target nerve.


Wireless unit 215, or catheter 212 itself, may also include a wireless information unit (not shown), for example, an RFID tag or wireless chip, or other unique coded information related to the catheter 212 including, for example, the catheter serial number and construction change level. For instance, as improvements to the catheter are made over time, each improvement is recorded as a change level. This change level may, for example, include an electrode material change or an electrode surface finish. These changes may permit the use of a more effective stimulation pulse stream. The control unit 230 may evaluate the change level code and determine whether a new stimulation program installed on the control unit 230 is applicable to that catheter 210, as the software of control unit 230 may also be updated periodically. The change level code may avoid the creation of “generic” pirated clones by detecting false codes and preventing the system from operating if a false code is detected. As such, this would also reduce the risks to the patient, medical professional, and manufacturer by eliminating the risk of inferior devices being improperly used without the proper clinical testing and approval. The wireless information unit may further record usage data for catheter 212, including, for example, time of day of use, duration of use, number of times used, and other information related to communications from control unit 230. Hub 211 with wireless unit 215 does not require a wired connection between the control unit 230 and the catheter 212, reducing the assembly time for a medical professional and reducing the risk of signal interference, misalignment, cable snagging, and other human errors.


Alternatively, though not shown, wireless unit 215 may receive all data wirelessly from control unit 230, but the low voltage power necessary for the receiver in wireless unit 215 may be delivered by a low-cost three conductor cable from the control unit 230. This arrangement allows the system to operate for long periods of time without the risk of running low on battery power. Although this arrangement requires a cable for power, the arrangement nevertheless results in a minimal number of pins in the connections to the control unit, thereby enhancing reliability and reducing the risk of misalignment.


Radiopaque Catheters and Orientation Indicators



FIGS. 13 and 14 illustrate an alternative catheter 312 with similar elements to the catheter 12 of FIG. 1 shown by 300 added to the reference numbers. Aspects shown in FIGS. 13 and 14 may be incorporated in any of the foregoing catheter examples in order to ensure that the catheter 312 is aligned properly. As shown in FIG. 13, catheter 312 may be radiopaque and may be viewed via one or more imaging systems, for example, via fluoroscopy, X-ray, or other imaging methods. Catheter 312 may be made to be radiopaque by using a polymer that is approximately 20% BaSO4, or by printing radiopaque ink on the exterior of the catheter. Radiopaque catheter 312 may include two proximal electrode assemblies 314, each with six proximal electrodes 348 exposed via proximal windows 344, and two distal electrode assemblies 316, each with three distal electrodes 350 exposed via distal windows 346. Electrodes 348, 350 may also be radiopaque, for example, containing 10% Platinum-Iridium (PtIr), and may appear to be darker than the radiopaque catheter 312.



FIG. 13 shows an anterior view of radiopaque catheter 312 properly aligned such that proximal electrodes 348 face substantially posteriorly (to the patient's back) to stimulate the left phrenic nerve 26, and distal electrodes 350 face substantially laterally (to the patient's right) to stimulate the right phrenic nerve 28. When viewed anteriorly, the proximal electrodes 348 may appear in two aligned rows of six electrodes in the center of the catheter 312. The distal electrodes 350 may appear in a single row of six electrodes positioned toward the lateral (patient's right) edge of the catheter 312. Moreover, the proximal electrodes 348 and three alternating distal electrodes 350 may appear to be darker than the catheter shaft 312, even though these electrodes are posterior facing. Three alternating distal electrodes 350 may appear to be even darker than the other electrodes as these electrodes are anterior facing. If the catheter 312 and electrodes 348, 350 appear differently than shown and described, the catheter 312 and electrodes 348, 350 are likely improperly positioned. As such, a medical professional may use this visualization to ensure that the catheter 312 and electrodes 348, 350 are positioned properly when stimulating or preparing to stimulate target nerves.



FIG. 14 illustrates an additional example of catheter 312 that is radiopaque and may aid in ensuring the catheter 312 and electrodes 348, 350 are properly positioned. As with FIG. 13, when viewed anteriorly via an imaging system, a properly positioned catheter 312 may include two rows of six proximal electrodes 348 in the center of the catheter 312, and one row of six distal electrodes 350 toward the lateral (patient's right) edge of the catheter 312. The proximal electrodes 348 and three alternating distal electrodes 350 may appear darker than the catheter 312, and three alternating distal electrodes 350 may appear even darker than the other electrodes.


As shown in FIG. 14, catheter 312 may further include one or more radiopaque markers 321. For example, catheter 312 may include a one radiopaque marker 321 at a distal end of the catheter 312, and one radiopaque marker 321 at a proximal end of the catheter 312. Radiopaque markers 321 may be formed by printing or otherwise applying radiopaque ink to the catheter 312. When viewed with an imaging system, the orientation and/or appearance of the radiopaque markers 321 may allow a medical professional to determine whether the catheter 312 is properly positioned and/or oriented. For example, the distal radiopaque marker 321 may be a check mark, and the proximal radiopaque marker 321 may be a smiley face, as shown in FIG. 14. When viewed anteriorly, if the checkmark is longer on the right side, and the smiley face is right-side up, then the catheter 312 is properly oriented. Otherwise, orientation is not proper, and the user may adjust the position of catheter 312.


Catheter 312 may include a further radiopaque orientation marker, for example, orientation stripe 323. Orientation stripe 323 may extend longitudinally along at least a portion of the length of the catheter 312 such that when viewed anteriorly with an imaging system, the orientation stripe 323 passes through the middle of the catheter 312. Orientation stripe 323 may bisect or align with a midpoint of the radiopaque markers 321. Orientation stripe 323 may be positioned on catheter 312 such that, when the catheter 312 and electrodes 348, 350 are properly positioned and viewed anteriorly using an imaging system, orientation stripe 323 passes evenly between the two rows of proximal electrodes 348 and passes to the medial (patient's left) side of the one row of distal electrodes 350. Orientation stripe 323 may be formed during the formation of the catheter 312, for example, during an extrusion. Orientation stripe 323 may include a different color or pattern, may be laser marked, may be printed with radiopaque ink, may be a radiopaque wire introduced into a dedicated lumen of the catheter body, or may be formed by any other appropriate methods. If the catheter 312 is not properly positioned, the catheter 312 may be adjusted until the electrodes 348, 350, radiopaque markers 321, and orientation stripe 323 appear when viewed anteriorly as illustrated in FIG. 14.


Orientation stripe 323 may be also be used to control the orientation of the catheter 312 while inserting catheter 312 into a patient without taking an x-ray or using another visualization technique. For example, orientation stripe 323 may run longitudinally from the distal end to the proximal end of catheter 312. Therefore, as long as the catheter 312 is not undergoing torsion, a medical professional is able to determine the orientation of the distal end, which is inserted into the patient and thus not visible without imaging technology, by observing the location of the orientation stripe 323 on the proximal end that extends proximally from the patient.


Radiopaque catheter 312 may also include an orientation hub 325. For example, the shape and size of orientation hub 325 may be such that orientation hub may be sutured or otherwise attached in only one orientation. Orientation hub 325 may have an apex 327 that circumferentially aligns with orientation stripe 323 on catheter 312, and which is opposite to a flat bottom that may rest on a patient's chest or another surface. The flat bottom may also include two attachment members or suture tabs 329 extending from the bottom such that the bottom may be coupled to other elements in the proper orientation. Additionally or alternatively, orientation hub 325 may include a wireless unit as discussed above with respect to FIG. 12.


Catheter 312 may include all or a portion of the aforementioned positioning markers. Additionally, a medical professional may use different positioning markers to ensure the catheter 312 is positioned properly as different markers may exhibit greater visibility depending on the patient, the imaging system, and other variables. Catheter 312 and the various positioning and orientation markers may be modified and/or customized depending on the patient. For example, fewer electrodes 348, 350 may be used with a smaller patient, for example, a neonate. Alternatively, a patient with abnormal nerve locations may require a different catheter orientation and/or arrangement.


Other Alternative Embodiments and Interpretation of Terms


As noted earlier, any of the components and features of any of the embodiments disclosed herein may be combined and used in any suitable combinations with any of the other components and features disclosed herein. However, for the sake of example, some ways in which the described example embodiments may be varied include:

    • different numbers of electrodes;
    • different electrode configurations;
    • different electrode fixing (crimp, adhesive, microweld, rivet, etc.);
    • different electrode shape (round, oval, circular, rectangular, etc.);
    • different electrode material;
    • different electrode surface areas;
    • different electrode spacing;
    • different number or shapes of lumens;
    • different window shape/dimensions;
    • different catheter profile (e.g., +/−9 Fr);
    • different catheter length; and/or
    • different steering mechanism.


As mentioned above, the use of the various catheter embodiments allows for an increase in the number of available lumens within the catheter. The size of the catheter may also be reduced, for example, for use in neonatal patients or patients who require a smaller catheter. Ribbon cables increase the longitudinal flexibility of the catheter and the electrode connections during the manipulation and use of the catheter. Using ASICs and/or wireless connections reduces the number of cables and connections the medical professional must properly connect and avoid during various procedures, while still properly and accurately stimulating various internal nerves. Additionally, radiopaque catheters, radiopaque electrodes, radiopaque markers, and orientation markers may aid a medical professional in locating the position of the catheter and orienting the catheter in order to most effectively stimulate the patient's nerves.


Unless the context clearly requires otherwise, throughout the description and the claims:

    • “comprise,” “comprising,” and the like are to be construed in an inclusive sense, as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to”;
    • “connected,” “coupled,” or any variant thereof, means any connection or coupling, either direct or indirect, between two or more elements; the coupling or connection between the elements can be physical, electrical, or a combination thereof;
    • “herein,” “above,” “below,” and words of similar import, when used to describe this specification, shall refer to this specification as a whole, and not to any particular portions of this specification;
    • “or,” in reference to a list of two or more items, covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list; and
    • the singular forms “a,” “an,” and “the” also include the meaning of any appropriate plural forms.


Words that indicate directions such as “vertical,” “transverse,” “horizontal,” “upward,” “downward,” “forward,” “backward,” “inward,” “outward,” “left,” “right,” “front,” “back,” “top,” “bottom,” “below,” “above,” “under,” and the like, used in this description and any accompanying claims (where present), depend on the specific orientation of the apparatus described and illustrated. The subject matter described herein may assume various alternative orientations. Accordingly, these directional terms are not strictly defined and should not be interpreted narrowly.


Specific examples of systems, methods and apparatus have been described herein for purposes of illustration. These are only examples. The technology provided herein can be applied to systems other than the example systems described above. Many alterations, modifications, additions, omissions, and permutations are possible within the practice of this invention. This invention includes variations on described embodiments that would be apparent to the skilled addressee, including variations obtained by: replacing features, elements and/or acts with equivalent features, elements and/or acts; mixing and matching of features, elements and/or acts from different embodiments; combining features, elements and/or acts from embodiments as described herein with features, elements and/or acts of other technology; and/or omitting combining features, elements and/or acts from described embodiments.


It is therefore intended that the following appended claims and claims hereafter introduced are interpreted to include all such modifications, permutations, additions, omissions, and sub-combinations as may reasonably be inferred. The scope of the claims should not be limited by the preferred embodiments set forth in the examples, but should be given the broadest interpretation consistent with the description as a whole.

Claims
  • 1. A catheter, comprising: an outer sheath defining a plurality of apertures therethrough;a body defining at least one longitudinal lumen therein, wherein at least a portion of the body is radially inward of the outer sheath, and the apertures are radially outward of the lumen;a plurality of electrodes positioned in or on the catheter, each electrode being electrically exposed through an aperture of the plurality of apertures; anda ribbon cable extending through the lumen and including a plurality of leads, the plurality of leads being electrically connected to the plurality of electrodes,wherein the plurality of apertures includes a plurality of proximal apertures and a plurality of distal apertures, the plurality of proximal apertures including two longitudinally extending rows of proximal apertures, and wherein the outer sheath includes (1) a first radiopaque feature at a distal portion of the sheath for confirming an orientation of the distal apertures and (2) a second radiopaque feature at a proximal portion of the sheath and positioned circumferentially opposite to a line extending between the two rows of proximal apertures.
  • 2. The catheter of claim 1, wherein the lumen is a groove exposed along the circumference of the body along at least a portion of the length of the body, the groove being at least partially covered by the outer sheath.
  • 3. The catheter of claim 1, wherein the plurality of leads are at least partially surrounded by a non-conducting material; and wherein the ribbon cable is electrically connected to at least one electrode via a connection.
  • 4. The catheter of claim 1, wherein the ribbon cable includes a plurality of corrugations.
  • 5. The catheter of claim 4, further including at least one filler positioned within at least a portion of the corrugations, and wherein the corrugations are positioned radially inward of at least one electrode.
  • 6. The catheter of claim 1, further including: at least one fluid lumen and a guide wire lumen, and a connector feed and an application specific integrated circuit radially inward or outward of the outer sheath, wherein the application specific integrated circuit connects the connector feed to the ribbon cable.
  • 7. The catheter of claim 6, wherein the ribbon cable includes three branches of ribbon cable; wherein the at least one longitudinal lumen includes three longitudinal lumens spaced circumferentially around an exterior of the body and radially inward of the outer sheath; andwherein the three branches extend distally from the application specific integrated circuit, and each of the three branches connects to at least one electrode through a corresponding longitudinal lumen.
  • 8. The catheter of claim 7, wherein one branch of the three branches includes at least one lead that electrically connects at least one proximal electrode and at least one other lead that electrically connects at least one distal electrode.
  • 9. The catheter of claim 1, wherein the plurality of distal apertures includes two longitudinally extending rows comprising a first row of distal apertures and a second row of distal apertures; andwherein one row of the two rows of proximal apertures is circumferentially aligned with the first row of distal apertures.
  • 10. The catheter of claim 9, wherein the first radiopaque feature is for confirming an orientation of the first row of distal apertures relative to the second row of distal apertures.
  • 11. The catheter of claim 9, wherein the other of the two rows of proximal apertures is circumferentially offset from both the first row of distal apertures and the second row of distal apertures.
  • 12. The catheter of claim 10, further including a hub, wherein the hub includes an orientation feature and a port, wherein the port is configured to couple the hub to a proximal portion of the catheter in a particular orientation.
  • 13. The catheter of claim 1, wherein the lumen and the ribbon cable are recessed from an outer surface of the body.
  • 14. The catheter of claim 1, wherein the lumen is a first lumen, and the ribbon cable is a first ribbon cable, and wherein the catheter further comprises a second ribbon cable extending through a second lumen defined by the body.
  • 15. The catheter of claim 14, wherein the first lumen and the second lumen are spaced circumferentially around an exterior of the body.
  • 16. The catheter of claim 1, wherein the ribbon cable includes three or more leads arranged in a row.
  • 17. The catheter of claim 1, wherein the ribbon cable has a single, flexible planar structure.
  • 18. The catheter of claim 1, wherein the outer sheath has an inner surface exposed to the at least one longitudinal lumen and an outer surface comprising the outermost surface of at least a portion of the catheter.
  • 19. A catheter, comprising: an outer sheath defining a plurality of apertures therethrough;a body defining at least one lumen recessed within an outer surface of the body, wherein the apertures are radially outward of the lumen, and wherein an inner surface of the sheath is exposed to the ribbon cable, and an outer surface of the sheath is the outermost surface of at least a portion of the catheter;a plurality of electrodes positioned in or on the catheter, each electrode being electrically exposed through an aperture of the plurality of apertures; anda ribbon cable extending through the lumen, in a single flexible planar configuration, and including at least three leads arranged in a row, the plurality of at least three leads being electrically connected to the plurality of electrodes.
  • 20. The catheter of claim 19, wherein the lumen is a first lumen, and the ribbon cable is a first ribbon cable, and wherein the catheter further comprises a second ribbon cable extending through a second lumen defined by the body.
  • 21. The catheter of claim 19, wherein the lumen is a groove exposed along the circumference of the body along at least a portion of the length of the body, the groove being at least partially covered by the outer sheath.
  • 22. The catheter of claim 19, wherein the plurality of apertures includes a first row of proximal apertures, a second row of proximal apertures, a first row of distal apertures, and a second row of distal apertures, and wherein the first row of proximal apertures is circumferentially aligned with one of either the first row of distal apertures or the second row of distal apertures, and the second row of proximal apertures is circumferentially offset from both the first row of distal apertures and the second row of distal apertures.
US Referenced Citations (645)
Number Name Date Kind
1693734 Waggoner Dec 1928 A
2532788 Sarnoff Dec 1950 A
2664880 Wales, Jr. Jan 1954 A
3348548 Chardack Oct 1967 A
3470876 John Oct 1969 A
3769984 Muench Nov 1973 A
3804098 Friedman Apr 1974 A
3817241 Grausz Jun 1974 A
3835864 Rasor et al. Sep 1974 A
3847157 Caillouette et al. Nov 1974 A
3851641 Toole et al. Dec 1974 A
3896373 Zelby Jul 1975 A
3938502 Bom Feb 1976 A
3983881 Wickham Oct 1976 A
4054881 Raab Oct 1977 A
4072146 Howes Feb 1978 A
4114601 Abels Sep 1978 A
4173228 Childress et al. Nov 1979 A
4249539 Mezrich et al. Feb 1981 A
4317078 Weed et al. Feb 1982 A
4380237 Newbower Apr 1983 A
4407294 Vilkomerson Oct 1983 A
4416289 Bresler Nov 1983 A
4431005 McCormick Feb 1984 A
4431006 Trimmer et al. Feb 1984 A
4445501 Bresler May 1984 A
RE31873 Howes Apr 1985 E
4573481 Bullara Mar 1986 A
4586923 Gould et al. May 1986 A
4587975 Salo et al. May 1986 A
4643201 Stokes Feb 1987 A
4674518 Salo Jun 1987 A
4681117 Brodman et al. Jul 1987 A
4683890 Hewson Aug 1987 A
4697595 Breyer et al. Oct 1987 A
4706681 Breyer et al. Nov 1987 A
4771788 Millar Sep 1988 A
4819662 Heil, Jr. et al. Apr 1989 A
4827935 Geddes et al. May 1989 A
4830008 Meer May 1989 A
4840182 Carlson Jun 1989 A
4852580 Wood Aug 1989 A
4860769 Fogarty et al. Aug 1989 A
4905698 Strohl, Jr. et al. Mar 1990 A
4911174 Pederson et al. Mar 1990 A
4934049 Kiekhafer et al. Jun 1990 A
4944088 Doan et al. Jul 1990 A
4951682 Petre Aug 1990 A
4957110 Vogel et al. Sep 1990 A
4989617 Memberg et al. Feb 1991 A
5005587 Scott Apr 1991 A
5036848 Hewson Aug 1991 A
5042143 Holleman et al. Aug 1991 A
5056519 Vince Oct 1991 A
5115818 Holleman et al. May 1992 A
5146918 Kallok et al. Sep 1992 A
5170802 Mehra Dec 1992 A
5184621 Vogel et al. Feb 1993 A
5224491 Mehra Jul 1993 A
5243995 Maier Sep 1993 A
5265604 Vince Nov 1993 A
5267569 Lienhard Dec 1993 A
5314463 Camps et al. May 1994 A
5316009 Yamada May 1994 A
5324322 Grill, Jr. et al. Jun 1994 A
5330522 Kreyenhagen Jul 1994 A
5345936 Pomeranz et al. Sep 1994 A
5383923 Webster, Jr. Jan 1995 A
5411025 Webster, Jr. May 1995 A
5417208 Winkler May 1995 A
5451206 Young Sep 1995 A
5456254 Pietroski et al. Oct 1995 A
5465717 Imran et al. Nov 1995 A
5476498 Ayers Dec 1995 A
5486159 Mahurkar Jan 1996 A
5507725 Savage et al. Apr 1996 A
5524632 Stein et al. Jun 1996 A
5527358 Mehmanesh et al. Jun 1996 A
5531686 Lundquist et al. Jul 1996 A
5549655 Erickson Aug 1996 A
5555618 Winkler Sep 1996 A
5567724 Kelleher et al. Oct 1996 A
5584873 Shoberg et al. Dec 1996 A
5604231 Smith et al. Feb 1997 A
5665103 Lafontaine et al. Sep 1997 A
5678535 Dimarco Oct 1997 A
5683370 Luther et al. Nov 1997 A
5709853 Iino et al. Jan 1998 A
5716392 Bourgeois et al. Feb 1998 A
5733255 Dinh et al. Mar 1998 A
5755765 Hyde et al. May 1998 A
5776111 Tesio Jul 1998 A
5779732 Amundson Jul 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5788681 Weaver et al. Aug 1998 A
5813399 Isaza et al. Sep 1998 A
5814086 Hirschberg et al. Sep 1998 A
RE35924 Winkler Oct 1998 E
5824027 Hoffer et al. Oct 1998 A
5827192 Gopakumaran et al. Oct 1998 A
5916163 Panescu et al. Jun 1999 A
5944022 Nardella et al. Aug 1999 A
5954761 Machek et al. Sep 1999 A
5967978 Littmann et al. Oct 1999 A
5971933 Gopakumaran et al. Oct 1999 A
5983126 Wittkampf Nov 1999 A
6006134 Hill et al. Dec 1999 A
6024702 Iversen Feb 2000 A
6096728 Collins et al. Aug 2000 A
6120476 Fung et al. Sep 2000 A
6123699 Webster, Jr. Sep 2000 A
6126649 Vantassel et al. Oct 2000 A
6136021 Tockman et al. Oct 2000 A
6157862 Brownlee et al. Dec 2000 A
6161029 Spreigl et al. Dec 2000 A
6166048 Bencherif Dec 2000 A
6171277 Ponzi Jan 2001 B1
6183463 Webster, Jr. Feb 2001 B1
6198970 Freed et al. Mar 2001 B1
6198974 Webster, Jr. Mar 2001 B1
6201994 Warman et al. Mar 2001 B1
6208881 Champeau Mar 2001 B1
6210339 Kiepen et al. Apr 2001 B1
6212435 Lattner et al. Apr 2001 B1
6216045 Black et al. Apr 2001 B1
6236892 Feler May 2001 B1
6240320 Spehr et al. May 2001 B1
6249708 Nelson Jun 2001 B1
6251126 Ottenhoff et al. Jun 2001 B1
6269269 Ottenhoff et al. Jul 2001 B1
6292695 Webster, Jr. et al. Sep 2001 B1
6295475 Morgan Sep 2001 B1
6360740 Ward et al. Mar 2002 B1
6397108 Camps et al. May 2002 B1
6400976 Champeau Jun 2002 B1
6415183 Scheiner et al. Jul 2002 B1
6415187 Kuzma et al. Jul 2002 B1
6438427 Rexhausen et al. Aug 2002 B1
6445953 Bulkes et al. Sep 2002 B1
6449507 Hill et al. Sep 2002 B1
6463327 Lurie et al. Oct 2002 B1
6493590 Wessman et al. Dec 2002 B1
6508802 Rosengart et al. Jan 2003 B1
6526321 Spehr Feb 2003 B1
6569114 Ponzi et al. May 2003 B2
6584362 Scheiner et al. Jun 2003 B1
6585718 Hayzelden et al. Jul 2003 B2
6587726 Lurie et al. Jul 2003 B2
6602242 Fung et al. Aug 2003 B1
6610713 Tracey Aug 2003 B2
6630611 Malowaniec Oct 2003 B1
6643552 Edell et al. Nov 2003 B2
6651652 Waard Nov 2003 B1
6682526 Jones et al. Jan 2004 B1
6702780 Gilboa et al. Mar 2004 B1
6718208 Hill et al. Apr 2004 B2
6721603 Zabara et al. Apr 2004 B2
6757970 Kuzma et al. Jul 2004 B1
6778854 Puskas Aug 2004 B2
6779257 Kiepen et al. Aug 2004 B2
6844713 Steber et al. Jan 2005 B2
RE38705 Hill et al. Feb 2005 E
6881211 Schweikert et al. Apr 2005 B2
6885888 Rezai Apr 2005 B2
6907285 Denker et al. Jun 2005 B2
6934583 Weinberg et al. Aug 2005 B2
6981314 Black et al. Jan 2006 B2
6999820 Jordan Feb 2006 B2
7018374 Schon et al. Mar 2006 B2
7047627 Black et al. May 2006 B2
7071194 Teng Jul 2006 B2
7072720 Puskas Jul 2006 B2
7077823 McDaniel Jul 2006 B2
7082331 Park et al. Jul 2006 B1
7130700 Gardeski Oct 2006 B2
7142903 Rodriguez et al. Nov 2006 B2
7149585 Wessman et al. Dec 2006 B2
7155278 King et al. Dec 2006 B2
7168429 Matthews et al. Jan 2007 B2
7184829 Hill et al. Feb 2007 B2
7206636 Turcott Apr 2007 B1
7212867 Van Venrooij et al. May 2007 B2
7225016 Koh May 2007 B1
7225019 Jahns et al. May 2007 B2
7229429 Martin et al. Jun 2007 B2
7231260 Wallace et al. Jun 2007 B2
7235070 Vanney Jun 2007 B2
7269459 Koh Sep 2007 B1
7277757 Casavant et al. Oct 2007 B2
7283875 Larsson et al. Oct 2007 B2
7340302 Falkenberg et al. Mar 2008 B1
7363085 Benser et al. Apr 2008 B1
7363086 Koh et al. Apr 2008 B1
7371220 Koh et al. May 2008 B1
7416552 Paul et al. Aug 2008 B2
7421296 Benser et al. Sep 2008 B1
7454244 Kassab et al. Nov 2008 B2
7519425 Benser et al. Apr 2009 B2
7519426 Koh et al. Apr 2009 B1
7522953 Gharib et al. Apr 2009 B2
7553305 Honebrink et al. Jun 2009 B2
7555349 Wessman et al. Jun 2009 B2
7569029 Clark et al. Aug 2009 B2
7591265 Lee et al. Sep 2009 B2
7593760 Rodriguez et al. Sep 2009 B2
7613524 Jordan Nov 2009 B2
7636600 Koh Dec 2009 B1
7670284 Padget et al. Mar 2010 B2
7672728 Libbus et al. Mar 2010 B2
7672729 Koh et al. Mar 2010 B2
7676275 Farazi et al. Mar 2010 B1
7676910 Kiepen et al. Mar 2010 B2
7697984 Hill et al. Apr 2010 B2
7747323 Libbus et al. Jun 2010 B2
7771388 Olsen et al. Aug 2010 B2
7783362 Whitehurst et al. Aug 2010 B2
7794407 Rothenberg Sep 2010 B2
7797050 Libbus et al. Sep 2010 B2
7813805 Farazi Oct 2010 B1
7819883 Westlund et al. Oct 2010 B2
7840270 Ignagni et al. Nov 2010 B2
7853302 Rodriguez et al. Dec 2010 B2
7869865 Govari et al. Jan 2011 B2
7891085 Kuzma et al. Feb 2011 B1
7925352 Stack et al. Apr 2011 B2
7949409 Bly et al. May 2011 B2
7949412 Harrison et al. May 2011 B1
7962215 Ignagni et al. Jun 2011 B2
7970475 Tehrani et al. Jun 2011 B2
7972323 Bencini et al. Jul 2011 B1
7974693 David et al. Jul 2011 B2
7974705 Zdeblick et al. Jul 2011 B2
7979128 Tehrani et al. Jul 2011 B2
7994655 Bauer et al. Aug 2011 B2
8000765 Rodriguez et al. Aug 2011 B2
8019439 Kuzma et al. Sep 2011 B2
8021327 Selkee Sep 2011 B2
8036750 Caparso et al. Oct 2011 B2
8050765 Lee et al. Nov 2011 B2
8052607 Byrd Nov 2011 B2
8104470 Lee et al. Jan 2012 B2
8116872 Tehrani et al. Feb 2012 B2
8121692 Haefner et al. Feb 2012 B2
8135471 Zhang et al. Mar 2012 B2
8140164 Tehrani et al. Mar 2012 B2
8147486 Honour et al. Apr 2012 B2
8160701 Zhao et al. Apr 2012 B2
8160711 Tehrani et al. Apr 2012 B2
8195297 Penner Jun 2012 B2
8200336 Tehrani et al. Jun 2012 B2
8206343 Racz Jun 2012 B2
8224456 Daglow et al. Jul 2012 B2
8233987 Gelfand et al. Jul 2012 B2
8233993 Jordan Jul 2012 B2
8239037 Glenn et al. Aug 2012 B2
8244358 Tehrani et al. Aug 2012 B2
8244359 Gelfand et al. Aug 2012 B2
8244378 Bly et al. Aug 2012 B2
8255056 Tehrani Aug 2012 B2
8256419 Sinderby et al. Sep 2012 B2
8265736 Sathaye et al. Sep 2012 B2
8265759 Tehrani et al. Sep 2012 B2
8275440 Rodriguez et al. Sep 2012 B2
8280513 Tehrani et al. Oct 2012 B2
8315713 Burnes et al. Nov 2012 B2
8321808 Goetz et al. Nov 2012 B2
8335567 Tehrani et al. Dec 2012 B2
8340783 Sommer et al. Dec 2012 B2
8348941 Tehrani Jan 2013 B2
8369954 Stack et al. Feb 2013 B2
8374704 Desai et al. Feb 2013 B2
8388541 Messerly et al. Mar 2013 B2
8388546 Rothenberg Mar 2013 B2
8391956 Zellers et al. Mar 2013 B2
8401640 Zhao et al. Mar 2013 B2
8401651 Caparso et al. Mar 2013 B2
8406883 Barker Mar 2013 B1
8406885 Ignagni et al. Mar 2013 B2
8412331 Tehrani et al. Apr 2013 B2
8412350 Bly Apr 2013 B2
8428711 Lin et al. Apr 2013 B2
8428726 Ignagni et al. Apr 2013 B2
8428730 Stack et al. Apr 2013 B2
8433412 Westlund et al. Apr 2013 B1
8442638 Libbus et al. May 2013 B2
8457764 Ramachandran et al. Jun 2013 B2
8467876 Tehrani Jun 2013 B2
8473068 Farazi Jun 2013 B2
8478412 Ignagni et al. Jul 2013 B2
8478413 Karamanoglu et al. Jul 2013 B2
8478426 Barker Jul 2013 B2
8483834 Lee et al. Jul 2013 B2
8504158 Karamanoglu et al. Aug 2013 B2
8504161 Kornet et al. Aug 2013 B1
8509901 Tehrani Aug 2013 B2
8509902 Cho et al. Aug 2013 B2
8509919 Yoo et al. Aug 2013 B2
8512256 Rothenberg Aug 2013 B2
8522779 Lee et al. Sep 2013 B2
8527036 Jalde et al. Sep 2013 B2
8532793 Morris et al. Sep 2013 B2
8554323 Haefner et al. Oct 2013 B2
8560072 Caparso et al. Oct 2013 B2
8560086 Just et al. Oct 2013 B2
8571662 Hoffer Oct 2013 B2
8571685 Daglow et al. Oct 2013 B2
8615297 Sathaye et al. Dec 2013 B2
8617228 Wittenberger et al. Dec 2013 B2
8620412 Griffiths et al. Dec 2013 B2
8620450 Tockman et al. Dec 2013 B2
8626292 McCabe et al. Jan 2014 B2
8630707 Zhao et al. Jan 2014 B2
8644939 Wilson et al. Feb 2014 B2
8644952 Desai et al. Feb 2014 B2
8646172 Kuzma et al. Feb 2014 B2
8650747 Kuzma et al. Feb 2014 B2
8676323 Ignagni et al. Mar 2014 B2
8676344 Desai et al. Mar 2014 B2
8694123 Wahlstrand et al. Apr 2014 B2
8696656 Abboud et al. Apr 2014 B2
8706223 Zhou et al. Apr 2014 B2
8706235 Karamanoglu et al. Apr 2014 B2
8706236 Ignagni et al. Apr 2014 B2
8718763 Zhou et al. May 2014 B2
8725259 Kornet et al. May 2014 B2
8738154 Zdeblick et al. May 2014 B2
8755889 Scheiner Jun 2014 B2
8774907 Rothenberg Jul 2014 B2
8781578 McCabe et al. Jul 2014 B2
8781582 Ziegler et al. Jul 2014 B2
8781583 Cornelussen et al. Jul 2014 B2
8801693 He et al. Aug 2014 B2
8805511 Karamanoglu et al. Aug 2014 B2
8838245 Lin et al. Sep 2014 B2
8858455 Rothenberg Oct 2014 B2
8863742 Blomquist et al. Oct 2014 B2
8886277 Kim et al. Nov 2014 B2
8897879 Karamanoglu et al. Nov 2014 B2
8903507 Desai et al. Dec 2014 B2
8903509 Tockman et al. Dec 2014 B2
8909341 Gelfand et al. Dec 2014 B2
8914113 Zhang et al. Dec 2014 B2
8918169 Kassab et al. Dec 2014 B2
8918987 Kuzma et al. Dec 2014 B2
8923971 Haefner et al. Dec 2014 B2
8942823 Desai et al. Jan 2015 B2
8942824 Yoo et al. Jan 2015 B2
8948884 Ramachandran et al. Feb 2015 B2
8968299 Kauphusman et al. Mar 2015 B2
8972015 Stack et al. Mar 2015 B2
8983602 Sathaye et al. Mar 2015 B2
9008775 Sathaye et al. Apr 2015 B2
9026231 Hoffer May 2015 B2
9037264 Just et al. May 2015 B2
9042981 Yoo et al. May 2015 B2
9072864 Putz Jul 2015 B2
9072899 Nickloes Jul 2015 B1
9108058 Hoffer Aug 2015 B2
9108059 Hoffer Aug 2015 B2
9125578 Grunwald Sep 2015 B2
9138580 Ignagni et al. Sep 2015 B2
9138585 Saha et al. Sep 2015 B2
9149642 McCabe et al. Oct 2015 B2
9168377 Hoffer Oct 2015 B2
9205258 Simon et al. Dec 2015 B2
9216291 Lee et al. Dec 2015 B2
9220898 Hoffer Dec 2015 B2
9226688 Jacobsen et al. Jan 2016 B2
9226689 Jacobsen et al. Jan 2016 B2
9242088 Thakkar et al. Jan 2016 B2
9259573 Tehrani et al. Feb 2016 B2
9295846 Westlund et al. Mar 2016 B2
9314618 Imran et al. Apr 2016 B2
9333363 Hoffer et al. May 2016 B2
9345422 Rothenberg May 2016 B2
9370657 Tehrani et al. Jun 2016 B2
9398931 Wittenberger et al. Jul 2016 B2
9415188 He et al. Aug 2016 B2
9427566 Reed et al. Aug 2016 B2
9427588 Sathaye et al. Aug 2016 B2
9474894 Mercanzini et al. Oct 2016 B2
9485873 Shah et al. Nov 2016 B2
9498625 Bauer et al. Nov 2016 B2
9498631 Demmer et al. Nov 2016 B2
9504837 Demmer et al. Nov 2016 B2
9532724 Grunwald et al. Jan 2017 B2
9533160 Brooke et al. Jan 2017 B2
9539429 Brooke et al. Jan 2017 B2
9545511 Thakkar et al. Jan 2017 B2
9561369 Burnes et al. Feb 2017 B2
9566436 Hoffer et al. Feb 2017 B2
9572982 Burnes et al. Feb 2017 B2
9597509 Hoffer et al. Mar 2017 B2
9615759 Hurezan et al. Apr 2017 B2
9623252 Sathaye et al. Apr 2017 B2
9662494 Young et al. May 2017 B2
9682235 O'Mahony et al. Jun 2017 B1
9694185 Bauer Jul 2017 B2
9717899 Kuzma et al. Aug 2017 B2
9724018 Cho et al. Aug 2017 B2
9744351 Gelfand et al. Aug 2017 B1
9776005 Meyyappan et al. Oct 2017 B2
9861817 Cho et al. Jan 2018 B2
9872989 Jung et al. Jan 2018 B2
9884178 Bouton et al. Feb 2018 B2
9884179 Bouton et al. Feb 2018 B2
9919149 Imran et al. Mar 2018 B2
9931504 Thakkar et al. Apr 2018 B2
9950167 Hoffer et al. Apr 2018 B2
9956396 Young et al. May 2018 B2
9968785 Hoffer et al. May 2018 B2
9968786 Bauer et al. May 2018 B2
20010052345 Niazi Dec 2001 A1
20020026228 Schauerte Feb 2002 A1
20020056454 Samzelius May 2002 A1
20020065544 Smits et al. May 2002 A1
20020087156 Maguire et al. Jul 2002 A1
20020128546 Silver Sep 2002 A1
20020188325 Hill et al. Dec 2002 A1
20030078623 Weinberg et al. Apr 2003 A1
20030195571 Burnes et al. Oct 2003 A1
20040003813 Banner et al. Jan 2004 A1
20040010303 Bolea et al. Jan 2004 A1
20040030362 Hill et al. Feb 2004 A1
20040044377 Larsson et al. Mar 2004 A1
20040064069 Reynolds et al. Apr 2004 A1
20040077936 Larsson et al. Apr 2004 A1
20040088015 Casavant et al. May 2004 A1
20040111139 McCreery Jun 2004 A1
20040186543 King et al. Sep 2004 A1
20040210261 King et al. Oct 2004 A1
20050004565 Vanney Jan 2005 A1
20050013879 Lin et al. Jan 2005 A1
20050021102 Ignagni et al. Jan 2005 A1
20050027338 Hill Feb 2005 A1
20050033136 Govari et al. Feb 2005 A1
20050033137 Oral et al. Feb 2005 A1
20050043765 Williams et al. Feb 2005 A1
20050065567 Lee et al. Mar 2005 A1
20050070981 Verma Mar 2005 A1
20050075578 Gharib et al. Apr 2005 A1
20050085865 Tehrani Apr 2005 A1
20050085866 Tehrani Apr 2005 A1
20050085867 Tehrani et al. Apr 2005 A1
20050085868 Tehrani et al. Apr 2005 A1
20050085869 Tehrani et al. Apr 2005 A1
20050096710 Kieval May 2005 A1
20050109340 Tehrani May 2005 A1
20050113710 Stahmann et al. May 2005 A1
20050115561 Stahmann et al. Jun 2005 A1
20050131485 Knudson et al. Jun 2005 A1
20050138791 Black et al. Jun 2005 A1
20050138792 Black et al. Jun 2005 A1
20050143787 Boveja et al. Jun 2005 A1
20050165457 Benser et al. Jul 2005 A1
20050182454 Gharib et al. Aug 2005 A1
20050187584 Denker et al. Aug 2005 A1
20050192655 Black et al. Sep 2005 A1
20050251238 Wallace et al. Nov 2005 A1
20050251239 Wallace et al. Nov 2005 A1
20050288728 Libbus et al. Dec 2005 A1
20050288730 Deem et al. Dec 2005 A1
20060030894 Tehrani Feb 2006 A1
20060035849 Spiegelman et al. Feb 2006 A1
20060058852 Koh et al. Mar 2006 A1
20060074449 Denker et al. Apr 2006 A1
20060122661 Mandell Jun 2006 A1
20060122662 Tehrani et al. Jun 2006 A1
20060130833 Younes Jun 2006 A1
20060142815 Tehrani et al. Jun 2006 A1
20060149334 Tehrani et al. Jul 2006 A1
20060155222 Sherman et al. Jul 2006 A1
20060167523 Tehrani et al. Jul 2006 A1
20060188325 Dolan Aug 2006 A1
20060195159 Bradley et al. Aug 2006 A1
20060217791 Spinka Sep 2006 A1
20060224209 Meyer Oct 2006 A1
20060229677 Moffitt et al. Oct 2006 A1
20060247729 Tehrani et al. Nov 2006 A1
20060253161 Libbus et al. Nov 2006 A1
20060253182 King Nov 2006 A1
20060258667 Teng Nov 2006 A1
20060259107 Caparso et al. Nov 2006 A1
20060282131 Caparso et al. Dec 2006 A1
20060287679 Stone Dec 2006 A1
20070005053 Dando Jan 2007 A1
20070021795 Tehrani Jan 2007 A1
20070027448 Paul Feb 2007 A1
20070087314 Gomo Apr 2007 A1
20070093875 Chavan et al. Apr 2007 A1
20070106357 Denker et al. May 2007 A1
20070112402 Grill et al. May 2007 A1
20070112403 Moffitt et al. May 2007 A1
20070118183 Gelfand et al. May 2007 A1
20070150006 Libbus et al. Jun 2007 A1
20070168007 Kuzma et al. Jul 2007 A1
20070173900 Siegel et al. Jul 2007 A1
20070191908 Jacob et al. Aug 2007 A1
20070196780 Ware et al. Aug 2007 A1
20070203549 Demarais et al. Aug 2007 A1
20070208388 Jahns et al. Sep 2007 A1
20070221224 Pittman et al. Sep 2007 A1
20070240718 Daly Oct 2007 A1
20070250056 Vanney Oct 2007 A1
20070250162 Royalty Oct 2007 A1
20070255379 Williams et al. Nov 2007 A1
20070265611 Ignagni et al. Nov 2007 A1
20070288076 Bulkes et al. Dec 2007 A1
20080039916 Colliou et al. Feb 2008 A1
20080065002 Lobl et al. Mar 2008 A1
20080125828 Ignagni et al. May 2008 A1
20080161878 Tehrani et al. Jul 2008 A1
20080167695 Tehrani et al. Jul 2008 A1
20080177347 Tehrani et al. Jul 2008 A1
20080183186 Bly et al. Jul 2008 A1
20080183187 Bly Jul 2008 A1
20080183239 Tehrani et al. Jul 2008 A1
20080183240 Tehrani et al. Jul 2008 A1
20080183253 Bly Jul 2008 A1
20080183254 Bly et al. Jul 2008 A1
20080183255 Bly et al. Jul 2008 A1
20080183259 Bly et al. Jul 2008 A1
20080183264 Bly et al. Jul 2008 A1
20080183265 Bly et al. Jul 2008 A1
20080188903 Tehrani et al. Aug 2008 A1
20080215106 Lee et al. Sep 2008 A1
20080288010 Tehrani et al. Nov 2008 A1
20080288015 Tehrani et al. Nov 2008 A1
20080312712 Penner Dec 2008 A1
20080312725 Penner Dec 2008 A1
20090024047 Shipley et al. Jan 2009 A1
20090036947 Westlund et al. Feb 2009 A1
20090118785 Ignagni et al. May 2009 A1
20090248122 Pianca Oct 2009 A1
20090275956 Burnes et al. Nov 2009 A1
20090275996 Burnes et al. Nov 2009 A1
20090276022 Burnes et al. Nov 2009 A1
20100022950 Anderson et al. Jan 2010 A1
20100036451 Hoffer Feb 2010 A1
20100077606 Black et al. Apr 2010 A1
20100094376 Penner Apr 2010 A1
20100114227 Cholette May 2010 A1
20100114254 Kornet May 2010 A1
20100198296 Ignagni et al. Aug 2010 A1
20100204766 Zdeblick et al. Aug 2010 A1
20100268311 Cardinal et al. Oct 2010 A1
20100319691 Lurie et al. Dec 2010 A1
20110060381 Ignagni et al. Mar 2011 A1
20110077726 Westlund et al. Mar 2011 A1
20110118815 Kuzma et al. May 2011 A1
20110230932 Tehrani et al. Sep 2011 A1
20110230935 Zdeblick Sep 2011 A1
20110230945 Ohtaka et al. Sep 2011 A1
20110270358 Davis et al. Nov 2011 A1
20110288609 Tehrani et al. Nov 2011 A1
20120035684 Thompson et al. Feb 2012 A1
20120053654 Tehrani et al. Mar 2012 A1
20120078320 Schotzko et al. Mar 2012 A1
20120130217 Kauphusman et al. May 2012 A1
20120158091 Tehrani et al. Jun 2012 A1
20120209284 Westlund et al. Aug 2012 A1
20120215278 Penner Aug 2012 A1
20120323293 Tehrani et al. Dec 2012 A1
20130018247 Glenn et al. Jan 2013 A1
20130018427 Pham et al. Jan 2013 A1
20130023972 Kuzma et al. Jan 2013 A1
20130030496 Karamanoglu et al. Jan 2013 A1
20130030497 Karamanoglu et al. Jan 2013 A1
20130030498 Karamanoglu et al. Jan 2013 A1
20130060245 Grunewald et al. Mar 2013 A1
20130116743 Karamanoglu et al. May 2013 A1
20130123891 Swanson May 2013 A1
20130131743 Yamasaki et al. May 2013 A1
20130158625 Gelfand et al. Jun 2013 A1
20130165989 Gelfand et al. Jun 2013 A1
20130167372 Black et al. Jul 2013 A1
20130197601 Tehrani et al. Aug 2013 A1
20130237906 Park et al. Sep 2013 A1
20130268018 Brooke et al. Oct 2013 A1
20130289686 Masson et al. Oct 2013 A1
20130296964 Tehrani Nov 2013 A1
20130296973 Tehrani et al. Nov 2013 A1
20130317587 Barker Nov 2013 A1
20130333696 Lee et al. Dec 2013 A1
20140067032 Morris et al. Mar 2014 A1
20140088580 Wittenberger et al. Mar 2014 A1
20140114371 Westlund et al. Apr 2014 A1
20140121716 Casavant et al. May 2014 A1
20140128953 Zhao et al. May 2014 A1
20140148780 Putz May 2014 A1
20140316486 Zhou et al. Oct 2014 A1
20140324115 Ziegler et al. Oct 2014 A1
20140378803 Geistert et al. Dec 2014 A1
20150018839 Morris et al. Jan 2015 A1
20150034081 Tehrani et al. Feb 2015 A1
20150045810 Hoffer et al. Feb 2015 A1
20150045848 Cho et al. Feb 2015 A1
20150119950 Demmer et al. Apr 2015 A1
20150148877 Thakkar May 2015 A1
20150165207 Karamanoglu Jun 2015 A1
20150196354 Haverkost et al. Jul 2015 A1
20150196356 Kauphusman et al. Jul 2015 A1
20150231348 Lee et al. Aug 2015 A1
20150250982 Osypka Sep 2015 A1
20150265833 Meyyappan et al. Sep 2015 A1
20150283340 Zhang et al. Oct 2015 A1
20150290476 Krocak et al. Oct 2015 A1
20150359487 Coulombe Dec 2015 A1
20150374252 De La Rama et al. Dec 2015 A1
20150374991 Morris et al. Dec 2015 A1
20160001072 Gelfand et al. Jan 2016 A1
20160101280 Thakkar Apr 2016 A1
20160144078 Young et al. May 2016 A1
20160193460 Xu et al. Jul 2016 A1
20160228696 Imran et al. Aug 2016 A1
20160239627 Cerny et al. Aug 2016 A1
20160256692 Baru Sep 2016 A1
20160310730 Martins et al. Oct 2016 A1
20160331326 Xiang et al. Nov 2016 A1
20160367815 Hoffer Dec 2016 A1
20170007825 Thakkar et al. Jan 2017 A1
20170013713 Shah et al. Jan 2017 A1
20170021166 Bauer et al. Jan 2017 A1
20170028191 Mercanzini et al. Feb 2017 A1
20170036017 Tehrani et al. Feb 2017 A1
20170050033 Wechter Feb 2017 A1
20170143973 Tehrani May 2017 A1
20170143975 Hoffer et al. May 2017 A1
20170196503 Narayan et al. Jul 2017 A1
20170224993 Sathaye et al. Aug 2017 A1
20170232250 Kim et al. Aug 2017 A1
20170252558 O'Mahony et al. Sep 2017 A1
20170291023 Kuzma et al. Oct 2017 A1
20170296812 O'Mahony et al. Oct 2017 A1
20170312006 McFarlin et al. Nov 2017 A1
20170312507 Bauer et al. Nov 2017 A1
20170312508 Bauer et al. Nov 2017 A1
20170312509 Bauer et al. Nov 2017 A1
20170326359 Gelfand et al. Nov 2017 A1
20170347921 Haber et al. Dec 2017 A1
20180001086 Bartholomew et al. Jan 2018 A1
20180008821 Gonzalez et al. Jan 2018 A1
20180110562 Govari et al. Apr 2018 A1
20180117334 Jung May 2018 A1
Foreign Referenced Citations (34)
Number Date Country
1652839 Aug 2005 CN
102143781 Aug 2011 CN
0993840 Apr 2000 EP
1304135 Apr 2003 EP
0605796 Aug 2003 EP
2489395 Aug 2012 EP
2801509 Jun 2001 FR
H08510677 Nov 1996 JP
2003503119 Jan 2003 JP
2010516353 May 2010 JP
2011200571 Oct 2011 JP
2012000195 Jan 2012 JP
9407564 Apr 1994 WO
9508357 Mar 1995 WO
9964105 Dec 1999 WO
9965561 Dec 1999 WO
0100273 Jan 2001 WO
02058785 Aug 2002 WO
03094855 Nov 2003 WO
2006110338 Oct 2006 WO
2006115877 Nov 2006 WO
2007053508 May 2007 WO
2008092246 Aug 2008 WO
2008094344 Aug 2008 WO
2009006337 Jan 2009 WO
2009134459 Nov 2009 WO
2010029842 Mar 2010 WO
2010148412 Dec 2010 WO
2011158410 Dec 2011 WO
2012106533 Aug 2012 WO
2013131187 Sep 2013 WO
2013188965 Dec 2013 WO
2015075548 May 2015 WO
2015109401 Jul 2015 WO
Non-Patent Literature Citations (58)
Entry
Atonica A., et al., “Vagal Control of Lymphocyte Release from Rat Thymus,” Journal of the Autonomic Nervous System, Elsevier, vol. 48(3), Aug. 1994, pp. 187-197.
Whaley K., et al., “C2 Synthesis by Human Monocytes is Modulated by a Nicotinic Cholinergic Receptor,” Nature, vol. 293, Oct. 15, 1981, pp. 580-582 (and reference page).
Borovikovaa L.V., et al., “Role of Vagus Nerve Signaling in CNI-1493-Mediated Suppression of Acute Inflammation,” Autonomic Neuroscience: Basic and Clinical, vol. 85 (1-3), Dec. 20, 2000, pp. 141-147.
Borovikovaa L.V., et al., “Vagus Nerve Stimulation Attenuates the Systemic Inflammatory Response to Endotoxin,” Mature, Macmillan Magazines Ltd, vol. 405, May 25, 2000, pp. 458-462.
Watkins L.R., et al., “Implications of Immune-to-Brain Communication for Sickness and Pain,” PNAS (Proceedings of the National Academy of Sciences of the USA), vol. 96 (14), Jul. 6, 1999, pp. 7710-7713.
Extended European Search Report for Application No. 14864542.7, dated Jun. 2, 2017, 8 pages.
Fleshner M., et al., “Thermogenic and Corticosterone Responses to Intravenous Cytokines (IL-1β and TNF-α) are Attenuated by Subdiaphragmatic Vagotomy,” Journal of Neuroimmunology, vol. 86, Jun. 1998, pp. 134-141.
Gaykema R.P.A. et al., “Subdiaphragmatic Vagotomy Suppresses Endotoxin-Induced Activation of Hypothalamic Corticotropin-Releasing Hormone Neurons and ACTH Secretion,” Endocrinology, The Endocrine Society, vol. 136 (10), 1995, pp. 4717-4720.
Gupta A.K., “Respiration Rate Measurement Based on Impedance Pneumography,” Data Acquisition Products, Texas Instruments, Application Report, SBAA181, Feb. 2011, 11 pages.
Guslandi M., “Nicotine Treatment for Ulcerative Colitis,” The British Journal of Clinical Pharmacology, Blackwell Science Ltd, vol. 48, 1999, pp. 481-484.
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Dec. 6, 2016, 4 pages.
Kawashima K., et al., “Extraneuronal Cholinergic System in Lymphocytes,” Pharmacology & Therapeutics, Elsevier, vol. 86, 2000, pp. 29-48.
Madretsma, G.S., et al., “Nicotine Inhibits the In-vitro Production of Interleukin 2 and Tumour Necrosis Factor-α by Human Mononuclear Cells,” Immunopharmacology, Elsevier, vol. 35 (1), Oct. 1996, pp. 47-51.
Nabutovsky, Y., et al., “Lead Design and Initial Applications of a New Lead for Long-Term Endovascular Vagal Stimulation,” PACE, Blackwell Publishing, Inc, vol. 30(1), Jan. 2007, pp. S215-S218.
Pavlovic D., et al., “Diaphragm Pacing During Prolonged Mechanical Ventilation of the Lungs could Prevent from Respiratory Muscle Fatigue,” Medical Hypotheses, vol. 60 (3), 2003, pp. 398-403.
Planas R.F., et al., “Diaphragmatic Pressures: Transvenous vs. Direct Phrenic Nerve Stimulation,” Journal of Applied Physiology, vol. 59(1), 1985, pp. 269-273.
Romanovsky, A.A., et al., “The Vagus Nerve in the Thermoregulatory Response to Systemic Inflammation,” American Journal of Physiology, vol. 273 (1 Pt 2), 1997, pp. R407-R413.
Salmela L., et al., “Verification of the Position of a Central Venous Catheter by Intra-Atrial ECG. When does this method fail?,” Acta Anasthesiol Scand, Vol. 37 (1), 1993, pp. 26-28.
Sandborn W.J., “Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis,” Annals of Internal Medicine, vol. 126 (5), Mar. 1, 1997, pp. 364-371.
Sato E., et al., “Acetylcholine Stimulates Alveolar Macrophages to Release Inflammatory Cell Chemotactic Activity,” American Journal of Physiology, vol. 274 (Lung Cellular and Molecular Physiology 18), 1998, pp. L970-L979.
Sato, K.Z., et al., “Diversity of mRNA Expression for Muscarinic Acetylcholine Receptor Subtypes and Neuronal Nicotinic Acetylcholine Receptor Subunits in Human Mononuclear Leukocytes and Leukemic Cell Lines,” Neuroscience Letters, vol. 266 (1), 1999, pp. 17-20.
Schauerte P., et al., “Transvenous Parasympathetic Nerve Stimulation in the Inferior Vena Cava and Atrioventricular Conduction,” Journal of Cardiovascular Electrophysiology, vol. 11 (1), Jan. 2000, pp. 64-69.
Schauerte P.N., et al., “Transvenous Parasympathetic Cardiac Nerve Stimulation: An Approach for Stable Sinus Rate Control,” Journal of Cardiovascular Electrophysiology, vol. 10 (11), Nov. 1999, pp. 1517-1524.
Scheinman R.I., et al., “Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids,” Science, vol. 270, Oct. 13, 1995, pp. 283-286.
Sher, M.E., et al., “The Influence of Cigarette Smoking on Cytokine Levels in Patients with Inflammatory Bowel Disease,” Inflammatory Bowel Diseases, vol. 5 (2), May 1999, pp. 73-78.
Steinlein, O., “New Functions for Nicotinic Acetylcholine Receptors?,” Behavioural Brain Research, vol. 95, 1998, pp. 31-35.
Sternberg E.M., (Series Editor) “Neural-Immune Interactions in Health and Disease,” The Journal of Clinical Investigation, vol. 100 (11), Dec. 1997, pp. 2641-2647.
Sykes., A.P., et al. “An Investigation into the Effect and Mechanisms of Action of Nicotine in Inflammatory Bowel Disease,” Inflammation Research, vol. 49, 2000, pp. 311-319.
Toyabe S., et al., “Identification of Nicotinic Acetylcholine Receptors on Lymphocytes in the Periphery as well as Thymus in Mice,” Immunology, vol. 92, 1997, pp. 201-205.
Van Dijk A.P.M., et al., “Transdermal Nicotine Inhibits Interleukin 2 Synthesis by Mononuclear Cells Derived from Healthy Volunteers,” European Journal of Clinical Investigation, vol. 28, 1998, pp. 664-671.
Watkins L.R., et al., “Blockade of Interleukin-1 Induced Hyperthermia by Subdiaphragmatic Vagotomy: Evidence for Vagal Mediation of Immune-Brain Communication,” Neuroscience Letters, vol. 183, 1995, pp. 27-31.
Ayas N.T., et al., “Prevention of Human Diaphragm Atrophy with Short periods of Electrical Stimulation,” American Journal of Respiratory and Critical Care Medicine, Jun. 1999, vol. 159(6), pp. 2018-2020.
Borovikova, et al., “Role of the Vagus Nerve in the Anti-Inflammatory Effects of CNI-1493,” Proceedings of the Annual Meeting of Professional Research Scientists: Experimental Biology 2000, Abstract 97.9, Apr. 15-18, 2000.
Chinese Search Report for Application No. CN2013/80023357.5, dated Jul. 24, 2015.
Co-pending U.S. Appl. No. 15/606,867, filed May 26, 2017.
Daggeti, W.M. et al., “Intracaval Electrophrenic Stimulation. I. Experimental Application during Barbiturate Intoxication Hemorrhage and Gang,” Journal of Thoracic and Cardiovascular Surgery, 1966, vol. 51 (5), pp. 676-884.
Daggeti, W.M. et al., “Intracaval electrophrenic stimulation. II. Studies on Pulmonary Mechanics Surface Tension Urine Flow and Bilateral Ph,” Journal of Thoracic and Cardiovascular Surgery, 1970, vol. 60(1 ), pp. 98-107.
De Gregorio, M.A. et al., “The Gunther Tulip Retrievable Filter: Prolonged Temporary Filtration by Repositioning within the Inferior Vena Cava,” Journal of Vascular and Interventional Radiology, 2003, vol. 14, pp. 1259-1265.
Deng Y-J et al., “The Effect of Positive Pressure Ventilation Combined with Diaphragm Pacing on Respiratory Mechanics in Patients with Respiratory Failure; Respiratory Mechanics,” Chinese critical care medicine, Apr. 2011, vol. 23(4), pp. 213-215.
European Search Report for Application No. 13758363, dated Nov. 12, 2015.
European Search Report for Application No. EP17169051.4, dated Sep. 8, 2017, 7 pages.
Extended European Search Report for Application No. 15740415.3, dated Jul. 7, 2017.
Frisch S., “A Feasibility Study of a Novel Minimally Invasive Approach for Diaphragm Pacing,” Master of Science Thesis, Simon Fraser University, 2009, p. 148.
Furman, S., “Transvenous Stimulation of the Phrenic Nerves,” Journal of Thoracic and Cardiovascular Surgery, 1971, vol. 62 (5), pp. 743-751.
Hoffer J.A. et al., “Diaphragm Pacing with Endovascular Electrodes”, IFESS 2010—International Functional Electrical Stimulation Society, 15th Anniversary Conference, Vienna, Austria, Sep. 2010.
Japanese Office Action in corresponding Japanese Application No. 2014-560202, dated Oct. 17, 2017, 5 pages.
Levine S., et al., “Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans,” New England Journal of Medicine, 2008, vol. 358, pp. 1327-1335.
Lungpacer: Therapy, News . . . Accessed Dec. 27, 2016.
Marcy, T.W. et al., “Diaphragm Pacing for Ventilatory Insufficiency,” Journal of Intensive Care Medicine, 1987, vol. 2 (6), pp. 345-353.
Meyyappan R., “Diaphragm Pacing during Controlled Mechanical Ventilation: Pre-Clinical Observations Reveal a Substantial Improvement in Respiratory Mechanics”, 17th Biennial Canadian Biomechanics Society Meeting, Burnaby, BC, Jun. 6-9, 2012.
Notification of Reasons for Rejection and English language translation issued in corresponding Japanese Patent Application No. 2015-517565, dated Mar. 28, 2017, 6 pages.
Onders R.,, “A Diaphragm Pacing as a Short-Term Assist to Positive Pressure Mechanical Ventilation in Critical Care Patients,” Chest, Oct. 24, 2007, vol. 132(4), pp. 5715-5728.
Onders R.,, “Diaphragm Pacing for Acute Respiratory Failure,” Difficult Decisions in Thoracic Surgery, Chapter 37, Springer-Verlag, 2011, M.K. Ferguson (ed.), pp. 329-335.
Onders R, et al., “Diaphragm Pacing with Natural Orifice Transluminal Endoscopic Surgery: Potential for Difficult-to-Wean Intensive Care Unit Patients,” Surgical Endoscopy, 2007, vol. 21, pp. 475-479.
Sandoval R., “A Catch/Ike Property-Based Stimulation Protocol for Diaphragm Pacing”, Master of Science Coursework project, Simon Fraser University, Mar. 2013.
Sarnoff, S.J. et al., “Electrophrenic Respiration,” Science, 1948, vol. 108, p. 482.
Wanner, A. et al., “Trasvenous Phrenic Nerve Stimulation in Anesthetized Dogs,” Journal of Applied Physiology, 1973, vol. 34 (4), pp. 489-494.
PCT Search Report dated Oct. 26, 2018 for PCT Application No. PCT/IB2018/000603, 7 pages.
Related Publications (1)
Number Date Country
20180339156 A1 Nov 2018 US